Pharmaceuticals
US FDA approves AstraZeneca's Crestor
09 February 2010
Scientists discover new treatment for chronic pain condition
08 February 2010
Newly engineered enzyme is a powerful staph antibiotic
06 February 2010
US FDA asks Ranbaxy to ensure plant standards compliance: report
05 February 2010
GlaxoSmithKline keeps jobs as 2009 profit jump 12 per cent to £8.73 billion
05 February 2010
Weight training improves cognitive function in seniors
05 February 2010
Rights groups contest human gene patent in US court
04 February 2010
GlaxoSmithKline inks up to $330 million drug deal with Apeiron Biologics
03 February 2010
Boston Scientific to pay J&J $1.73 billion in patent settlement
02 February 2010
Cephalon to acquire Swiss generic firm Mepha for $590 million
01 February 2010
GlaxoSmithKline may follow AstraZeneca in axing jobs: report
01 February 2010
Lupin receives US FDA approval for perindopril erbumine tablets
29 January 2010
Vitamin D can contribute to inflammatory bowel disease
29 January 2010
AstraZeneca reports profit, cuts 8,000 jobs to cut costs
29 January 2010
Enzon stockholders approve sale of specialty pharmaceutical business
28 January 2010
Widely used anti-obesity drug Sibutramine under FDA scanner
25 January 2010
Medtronic to acquire Invatec for $350 million
25 January 2010
Bayer to abandon haemophilia drug trial
25 January 2010
Researchers create new 'smart' nanocapsule delivery system for use in protein therapy
21 January 2010
Dr Reddy’ Labs posts consolidated net loss of Rs522 crore
21 January 2010
Alcon directors deride Novartis offer as grossly inadequate
20 January 2010
Ranbaxy acquires Biovel to enter vaccines business
19 January 2010
Bombay HC rejects plea to block Wockhardt deal with Abbott
18 January 2010
J&J adds several popular brands to Tylenol recall lots
16 January 2010
US justice dept hauls J&J to court for paying kickbacks
16 January 2010
EC probes pharma patent settlements to stall generic launches
13 January 2010
Wockhardt receives US FDA approval for antibacterial Levofloxacin
13 January 2010
LyondellBasell's `Moplen' resin used to replace steel in cleaning equipment
11 January 2010
Ministry stays DGGI ban on Natco’s generic cancer drug
11 January 2010
GSK inching closer to deal with Dr Reddy's?
08 January 2010
EU launches probe against Lundbeck for stalling generic drugs
08 January 2010
Orchid receives tentative FDA approval for Alzheimer’s drug Memantine tablet
08 January 2010
AstraZeneca settles another Nexium patent litigation for US sales
07 January 2010
Pfizer to market 40 Strides Arcolab generic drugs in the US
07 January 2010
Wockhardt gets US FDA approval for Alzheimer's drug Memantine
06 January 2010
Dr Reddy’s all-new diabetes drug shows good results
06 January 2010
Germany's Merz Pharmaceuticals to acquire BioForm Medical for $253 million
04 January 2010
Novartis acquires 52 per cent additional stake in Alcon for $28.1 billion
04 January 2010
Sun fails to dislodge Taro directors at general body
01 January 2010
Ranbaxy sells Chinese JV stake to state-owned firm
29 December 2009
Dr Reddy's to launch new drugs to boost domestic operations
28 December 2009
DCGI asks GSK to withdraw promotional campaign
26 December 2009
Ranbaxy again feels FDA heat – this time over US plant
26 December 2009
Teva-Kowa Pharma to acquire majority stake in Japanese genrics maker Taisho
24 December 2009
Boston Scientific pays $22 million to settle DOJ probe on kickbacks
24 December 2009
AstraZeneca to acquire Novexel for $350 million, expand alliance with Forest Labs
24 December 2009
Novartis acquires Corthera, gets global rights to new heart drug
23 December 2009
Glass Lewis supports Sun in Taro battle
23 December 2009
Lupin settles dispute with Forest Labs over Namenda
22 December 2009
Templeton cold to Taro’s plea for protection against Sun
22 December 2009
Seattle Genetics in antibody development deal with GSK
22 December 2009
Sanofi-aventis to acquire Chattem for $1.9 billion
21 December 2009
Ranbaxy to launch anti-hypertensive drug in six African countries
21 December 2009
Eli Lilly wins drug patent case vs Dr Reddy's in UK
18 December 2009
Sun Pharma advises Taro shareholders against voting at AGM
18 December 2009
India's FY09 pharma exports up 25 per cent at Rs38,433 crore
17 December 2009
J&J to buy ENT device maker Acclarent for $785 million
17 December 2009
Hospira of US buys Orchid’s injectables business
16 December 2009
Abbott to acquire Starlims Technologies for $123 million
15 December 2009
GSK and Intercell to develop innovative needle-free patch-based vaccines
12 December 2009
Taro again warns shareholders to stay away from Sun
12 December 2009
GlaxoSmithkline suspends operations at Andhra unit
11 December 2009
Glaxo targets emerging markets for acquisitions, tie-ups
11 December 2009
Biocon, HCG hospitals team up to fight cervical cancer
10 December 2009
EU raids pharmaceutical companies for anti-competitive business deals
10 December 2009
EKO Diagnostics to provide PET biomarkers to Siemens in Kolkata
09 December 2009
Ranbaxy exits JV with Japan’s Nippon Chemiphar
09 December 2009
Cipla gets notice for overpricing drugs; denies liability
08 December 2009
Celgene to acquire Gloucester Pharmaceuticals for $640 million
08 December 2009
Templeton switches sides; backs Sun on Taro takeover
02 December 2009
Genzyme starts shipments of drugs for two rare disorders
02 December 2009
Bayer Schering Pharma, Micromet to collaborate on developing new cancer antibody
02 December 2009
Pfizer inks $115 million deal with Israel’s Protalix for treatment of Gaucher’s disease
02 December 2009
Jubilant and Eli Lilly extend collaboration for five years
01 December 2009
Wockhardt settles with lender DBS Bank out of court
30 November 2009
Sanofi-Aventis signs drug localisation pact with Russia
28 November 2009
Ranbaxy launches generic herpes drug in US
27 November 2009
Sun Pharma gets FDA nod for selling generic drug
27 November 2009
Novartis gains rights to two oral investigational therapies for life-threatening blood disorders, cancers
25 November 2009
General Atlantic may buy stake in Strides Arcolab
24 November 2009
Merck wins summary judgment in Vioxx lawsuit in Texas
23 November 2009
Merck receives FDA approval for new fertility drug for women
21 November 2009
US FDA clears Boston Scientific's fully covered oesophageal stent
21 November 2009
Bristol-Myers to divest Mead Johnson for $7.69 billion
16 November 2009
Glenmark gets nod to market skin cream in US
16 November 2009
Cipla launches generic drugs for swine flu treatment
14 November 2009
Torrent opens exclusive human insulin unit for Novo Nordisk
14 November 2009
Aurbindo to merge subsidiary Trident Life Sciences Ltd
13 November 2009
Pfizer to slash R&D facilities post Wyeth merger
11 November 2009
Sanofi-Aventis expands Regeneron research deal to $1 billion
11 November 2009
India wins two creative Global Awards for healthcare communcations
11 November 2009
Enzon to sell specialty pharma business
09 November 2009
Dr Reddy's seeks US marketing rights for `Lipitor' generic
07 November 2009
J&J to axe more than 7,000 jobs in restructuring
04 November 2009
Spurious drugs: government announces reward scheme for whistleblowers
03 November 2009
Wockhardt reports Rs54 crore Q3 net loss
31 October 2009
Cadila launches first indigenously prepared TB drug
31 October 2009
Merck - Schering-Plough merger approved bu US, Swiss and Canadian regulators
30 October 2009
Sun Pharma earnings decline less-than-expected, Cipla earnings jump 82 per cent on forex gains
29 October 2009
Ranbaxy posts Rs186.08 crore in Q2 profits
27 October 2009
Impressive Q2 results see Lupin net surge 38 per cent to Rs160 crore
27 October 2009
Astellas to terminate development of anti-human antibody for RA
26 October 2009
EU watchdog places Biogen’s Tysabri under scanner
24 October 2009
Dr Reddy's July-September net zooms 106 per cent to Rs217 crore
23 October 2009
Pfizer unit fined record $1.3 billion for drug misbranding
19 October 2009
Pfizer completes Wyeth acquisition
16 October 2009
Eli Lilly to hive off Tippecanoe laboratory to Evonik Industries
15 October 2009
Suven Life's Alzheimer's drug candidate granted patents in 9 markets
14 October 2009
Piramal Lifesciences to invest Rs200 crore in drug researh
14 October 2009
Merck KGaA acquires Banagalore bioscience firm
13 October 2009
Novartis enters into $265-million schizophrenia drug deal with Vanda
13 October 2009
Novartis acquires global marketing rights for new drug from Paratek
09 October 2009
FDA advisory committee recommends approval of Pfizer’s Selzentry for HIV
09 October 2009
EU official raid Ranbaxy French unit
08 October 2009
Global pharmaceutical market to exceed $825 billion in 2010, says IMS
08 October 2009
Securities Tribunal asks Daiichi to offer Rs160 per Zenotech share
08 October 2009
GSK receives orders for 440 million doses of H1N1 vaccine
06 October 2009
Ranbaxy to market Daiichi Sankyo products in Mexico
05 October 2009
Hunduja's Gulf Oil sells IDL Specialty Chemicals to Biocon
01 October 2009
Boston Scientific and Johnson & Johnson settle patent disputes
30 September 2009
Academia Sinica joins Eli Lilly's new TB drug discovery programme
30 September 2009
Israeli drug firm Taro sues Sun Pharma in US
30 September 2009
Wockhardt receives US FDA approval for prostrate drug
29 September 2009
Merck & Co gets exclusive US rights for Afluria from CSL Biotherapies
29 September 2009
Lupin buys US rights for cholesterol drug Antara
29 September 2009
Abbott to acquire Belgian drug company Solvay for $6.6 billion
29 September 2009
Pharma giants worried about India’s generic expertise: Sharma
26 September 2009
Strides Arcolab launches H1N1 drug ‘Starflu’
26 September 2009
US Army claims `modest' success with AIDS vaccine trials in Thailand
24 September 2009
Wockhardt is top Indian pharma patentee; bags government award
24 September 2009
Astellas files suit against Teva for patent infringement in the US
24 September 2009
Venus Remedies outlicenses drug to South Korean firm
23 September 2009
Bayer to supply WHO with drug for African sleeping sickness
23 September 2009
Eli Lilly unveils plans to speed drug development
23 September 2009
Pfizer, Wyeth to sell animal drugs business to Boehringer
23 September 2009
Increasing incomes to boost costly drug sales: FICCI
22 September 2009
Merck, Wellcome Trust tie up to make affordable drugs in India
19 September 2009
Glaxo seeking stake in Dr Reddy’s: report
18 September 2009
Orchid receives USFDA approval for Zaleplon capsules
18 September 2009
Natco Pharma launches H1N1 drug ‘Natflu’
18 September 2009
Ranbaxy in-licenses cosmetic product Neuronox from Medy-Tox, South Korea
17 September 2009
Government opens window for retail sale of H1N1 drug
15 September 2009
Eli Lilly plans 5,500 job cuts to save $1 billion
15 September 2009
Suven Life Sciences secures 2 US patents for new chemicals
14 September 2009
BASF India board okays Ciba India merger
14 September 2009
Dr Reddy's scotches stake sale rumours
11 September 2009
Six new national pharmaceutical institutes to be set up on PPP model
11 September 2009
Biocon in hybrid drug development pact with Amylin
11 September 2009
Hyderabad’s Suven gets first payoff from Eli Lilly tie-up
08 September 2009
Sigma acquires Bristol-Myers Sqibb’s brands
07 September 2009
Aurobindo Pharma receives USFDA, Swissmedic approval for drugs
07 September 2009
States lose power to certify drug exports
07 September 2009
Ranbaxy launches authorised generic version of Validus's Rocaltrol
03 September 2009
GSK to test swine flu vaccine in India at selected sites
03 September 2009
LEO Pharma to Acquire Peplin for $287.5 million
03 September 2009
Bayer acquires two prescription dermatology product lines from SkinMedica in the US
03 September 2009
Dainippon Sumitomo close to buy US drug maker Sepracor
03 September 2009
Pfizer agrees to pay $2.3 billion to settle illegal marketing case
03 September 2009
Vivimed Labs completes buyback of FCCBs totalling $12.5 million
02 September 2009
Roche buys Lonza’s Singapore unit for $360 million
02 September 2009
AstraZeneca says its new anti-clotting drug better than Plavix
31 August 2009
Facet Biotech, Trubion in $196 million cancer drug deal
31 August 2009
Novartis moves Supreme Court on Glivec patent
29 August 2009
SC refuses to hear Roche's patent plea against Cipla
28 August 2009
Capital subsidy scheme for SSI pharma units to cover 179 items
27 August 2009
Cipla to raise Rs1500 crore; eyes Chinese partner
27 August 2009
Suven Life in talks with global pharma firms for its Alzheimer drug
25 August 2009
Ranbaxy's peptic ulcer drug cleared for US launch
25 August 2009
Warner Chilcott acquires P&G's global pharmaceuticals business for $3.1 billion
25 August 2009
Clinical trials for Valeant's shingles pain drug show no conclusive benefit
24 August 2009
Wockhardt completes sale of veterinary business to Vétoquinol
20 August 2009
Delhi High Court allows Cipla to sell generic cancer drug
19 August 2009
Panacea Biotec wins $222.37 million UNICEF contract for EasyFive vaccine
19 August 2009
Glenmark, Forest drug trial for COPD fails
19 August 2009
Glenmark faces GSK patent challenge in US over malaria drug
18 August 2009
Sun Pharma wins Gemzar patent motion against Eli Lilly in US court
18 August 2009
Aurobindo Pharma to acquire Trident Life Sciences
17 August 2009
Swine flu bolsters Indian pharma stocks
11 August 2009
Delhi HC rejects Reckitt Benkiser's claims against Wyeth
11 August 2009
India to crack down on fake Chinese drugs
11 August 2009
Merck, Schering-Plough shareholders approve $41-billion deal
10 August 2009
Pfizer, Mylan lower HIV drug prices for drug-resistant patients
08 August 2009
Aurobindo wins FDA nod for generic drug
08 August 2009
Dr Reddy's Lab launches skin patch pain reliever in India
06 August 2009
FDA bans Teva Animal Health’s veterinary drugs
03 August 2009
Sun Pharma settles Ethyol dispute with MedImmune
03 August 2009
Pfizer settles Trovan cases; pays $75 million to Nigerian state
31 July 2009
Sanofi-Aventis to acquire Merck's Merial stake for $4 billion
30 July 2009
Mylan says FDA approves its drug production
29 July 2009
Wockhardt sells its nutrition businesses to Abbott for $130 million
28 July 2009
Chinese-made fake Indian drugs hurt industry's image in Africa
28 July 2009
Sanofi-Aventis to acquire Shantha Biotech for Rs3,757 crore
27 July 2009
Azad hints at nexus between private-public vaccine units
25 July 2009
Dr Reddy's Q1 revenue up 21 per cent at Rs1,818 crore; eyes Rs15,000 crore turnover by 2012-13
23 July 2009
Bristol-Myers to acquire biotechnology company Medarex for $2.4 billion
23 July 2009
Merck’s Q2 profit falls, but beats expectations
22 July 2009
Dr Reddy's first quarter 2009-10 net doubles to Rs239 crore
21 July 2009
EC approves Pfizer's $68-billion acquisition of Wyeth
18 July 2009
Daiichi's 'low' bid for Zenotech faces new hurdles
16 July 2009
Merck, Schering-Plough settle Vyotorin dispute with states
16 July 2009
No decision yet on bringing essential drug under price control
11 July 2009
Streptokinase, A Life Saving Drug, Developed in collaboration with CSIR launched for Indian Market
11 July 2009
Cadila Pharmaceuticals launches joint venture with Novavax in India
10 July 2009
Sun Pharma to license key escitalopram patent applications to Lundbeck
10 July 2009
NPPA asks Cipla to pay for overcharging on drugs
10 July 2009
Ranbaxy's US subsidiary recalls anti-acne drug from US market
10 July 2009
Researchers claim phenoxodiol kills rapidly proliferating T-cells
09 July 2009
After US FDA raid, Sun Pharma’s US subsidiary slashes half its workforce
07 July 2009
Pharma's biggest boost comes from removal of fringe benefit tax
07 July 2009
Novartis' patent aplication for cancer drug Glivec rejected
07 July 2009
J&J to invest $1.5 billion in Elan’s Alzheimer’s drugs
03 July 2009
Lupin announces acquisition of worldwide rights for its nasal spray, AllerNaze
01 July 2009
J&J awarded $1.67 billion in patent suit against Abbott Laboratories
30 June 2009
Cash-strapped Wockhardt sells veterinary arm to France’s Vetoquinol
29 June 2009
Sun Pharma puts up brave face after FDA crackdown
27 June 2009
Sanofi’s diabetes drug may increase cancer risk: European study
27 June 2009
US FDA seizes drugs from Sun Pharma subsidiary Caraco
26 June 2009
Genzyme confident of restarting virus-hit Allston plant by August
26 June 2009
Sandoz receives approval for first-ever Japanese biosimilar
25 June 2009
Pfizer sweetens bid for India arm to Rs830 per share
25 June 2009
GSK signs drug pact with Chroma Therapeutics
24 June 2009
FDA calls for immediate stop to use of Zicam Cold Remedy and associated products
19 June 2009
Clinical trials using humans must now be registered
18 June 2009
Watson Pharmaceuticals to acquire Arrow Group for $1.75 billion
17 June 2009
Genzyme Corp shuts key facility to clean plant contamination
17 June 2009
Glaxo ties up with Dr Reddy's for emerging markets
15 June 2009
Eli Lilly made false claims of Zyprexa effectiveness
15 June 2009
China pushes fake "Indian" drugs in Africa
10 June 2009
GSK in new venture pact with Shenzhen Neptunus to make influenza vaccines in China
09 June 2009
Zydus Cadilla files application for anti-diabetes drug
04 June 2009
Adcock Ingram drops plans to acquire Cipla Medpro SA
02 June 2009
Bayer HealthCare and Genzyme finalise strategic alliance agreement
02 June 2009
AstraZeneca, Merck & Co to in phase 1 cancer drug research
01 June 2009
Daiichi Sankyo to raise $3 billion in bonds to repay Ranbaxy’s acquisition loan
01 June 2009
Bristol-Myers Squibb may acquire minority stake in Irish biotech firm
01 June 2009
Ranbaxy holds breath as FDA scrutinises corrective action plan
30 May 2009
Sanofi-Aventis inks cancer drug research deal with Exelixis
29 May 2009
Novartis ups offer price for Indian arm to Rs450 per share
28 May 2009
Skyepharma's new asthma drug `Flutiform, accepted for FDA review
27 May 2009
Ranbaxy seeks to downplay Malvinder exit
25 May 2009
Malvinder Singh relinquishes charge of Ranbaxy; Daiichi takes over
25 May 2009
J&J plans buyout of Cougar Biotech for $1 billion
23 May 2009
Ranbaxy acquires rights for Ochoa Labs’ skincare products
22 May 2009
Dr Reddy’s reorganises drug discovery operation; receives approval for three INDs
21 May 2009
Pfizer to expand presence in generic drugs marketing
21 May 2009
Merck plans buy-back of 35 per cent equity at Rs435 a share
20 May 2009
Biovail buys Cambridge Lab’s Huntington's disease drug
19 May 2009
Piramal Life Sciences gets regulatory nod for studies on cancer molecule
13 May 2009
Lupin reaches settlement with Wyeth on patented drug
13 May 2009
India gears up to mass-produce H1N1 flu vaccine
13 May 2009
Biocon's Kiran Mazumdar Shaw to receive Nikkei Asia Prize
11 May 2009
Aurobindo gets Australian nod for cholesterol pills
11 May 2009
Wockhardt to hive off animal health care business
07 May 2009
Ranbaxy's anti-malaria molecule enters Phase III clinical trial
06 May 2009
Pfizer brings patent infringement suits against Sun, Lupin, Wockhardt
06 May 2009
Jubilant signs research deal with Anglo-Swedish firm AstraZeneca
06 May 2009
Ranbaxy recalls Nitrofurantoin capsules in the US
02 May 2009
Wockhardt settles patent row with Orion Corporation
29 April 2009
Glenmark gets USFDA approval for cholesterol-lowering agent Ezetimibe
28 April 2009
Wockhardt reports Rs139 crore net loss in Q4'08
25 April 2009
WHO worried over drug-resistant malaria strain
25 April 2009
Cipla feels FDA heat: nine ‘deviations’ found
20 April 2009
GSK close to acquiring Stiefel Lab for $3 billion
20 April 2009
GSK, Pfizer to merge HIV businesses into a new company
17 April 2009
Natco, Dr Reddy’s tie up for cancer generics
16 April 2009
Proxy war heats up as Icahn calls for Amylin chairman’s resignation
16 April 2009
Sanofi to buy US cancer drug firm for about $500 million
15 April 2009
Pharmacy benefits manager Express Scripts buys peer NextRx for $4.68 billion
14 April 2009
Indian drug pricing regulator to launch national media campaign
14 April 2009
Glenmark’s molecule for pain disorders clear Phase I trials in Europe
13 April 2009
Pfizer seeks to increase stake in Indian arm
13 April 2009
Scottish and Chinese centres join hands for stem cell research
13 April 2009
FDA nod for Stride Arcolabs’ AIDS drug combo
11 April 2009
Lupin, Natco team up for generic launch of Shire's `Fosrenol'
09 April 2009
Genentech pulls drug from US market after health scare
09 April 2009
PPDI sells Piedmont R&D center; acquires Magen BioSciences
04 April 2009
Piramal Healthcare to shut down UK unit
02 April 2009
Glenmark to withdraw painkiller from US market
02 April 2009
Aurobindo's HIV drug, Ranbaxy's epillepsy drug get USFDA nod
01 April 2009
Wockhardt CMD Khorakiwala quits; Fortis takeover likely
01 April 2009
Cadilla’s ‘magic bullet’ polycap clears first big test
01 April 2009
Bayer sells 3 cancer drugs to Genzyme for $650 million
01 April 2009
Wockhardt’s debt hard pill to swallow for investors
01 April 2009
Ranbaxy to launch Daiichi's hypertension drug in India
31 March 2009
Zydus Cadila, Eli Lily tie up for cardiovascular drug research
30 March 2009
Glaxo, Sanofi in talks for Shanta Biotch takeover
30 March 2009
GSK eyes push into emerging markets through Asken buy
28 March 2009
After Matrix who will be delisted next?
28 March 2009
Novartis's open offer for Indian arm to begin on 14 May
27 March 2009
Strides Arcolab gets USFDA approval for its Bangalore facility
27 March 2009
US pharmaceutical company Hospira to cut 10 per cent of workforce
25 March 2009
Novartis makes open offer for 39 per cent in Indian arm
25 March 2009
Bristol-Myers, Syngene open new R&D facility
24 March 2009
UK, Australia okay drugs from Ranbaxy plant
24 March 2009
Hikal plans to take over its own pharma co
23 March 2009
J&J, GSK, Novartis eye world's top dermatologist Stiefel
21 March 2009
Dr Reddy’s pulling out of small global markets
21 March 2009
Dr Reddy’s sales in Russia and CIS top $150 million
19 March 2009
Aspirin can help prevent heart attacks, strokes
19 March 2009
Pfizer raises $13.5-billion debt to part finance Wyeth acquisition
18 March 2009
Astellas withdraws from race to acquire CV Therapeutics
16 March 2009
Cholesterol-lowering statins reduce severe asthma attacks and hospitalisations
16 March 2009
Matrix gets tentative US FDA nod for HIV inhibitor drug
13 March 2009
US court clears Dr Reddy’s in Omeprazole Mg OTC litigation
13 March 2009
Gilead Sciences to acquire CV Therapeutics for $1.4 billion
13 March 2009
Pharma majors under merger pressure after Merck-Schering deal
12 March 2009
Roche calls Genentech’s $112 a share demand unreasonable, may reach agreement on $95 a share
10 March 2009
Biocon arm Syngene in R&D pact with DuPont Crop Protection
09 March 2009
Merck to acquire Schering- Plough for $41 billion
09 March 2009
Pfizer sells insulin assets to Anti-diabetes drugmaker MannKind for $33 million
09 March 2009
Takeda shares plummet as FDA delays new drug
09 March 2009
Ranbaxy's cardio drug `Ramipril' gets US FDA approval
09 March 2009
Medicated patch can cause burns during MRI, warns FDA
09 March 2009
Roche raises Genentech offer from $86.50 to $93 a share
07 March 2009
New bill seeks to bring plants exporting drugs to US under FDA inspection
05 March 2009
Pfizer ties up with Aurobindo for generic drugs
04 March 2009
Pfizer acquires rights to several generics from Aurobindo
03 March 2009
Beckman to acquire Olympus unit for $800 million
02 March 2009
UK watchdog cautions parents giving cold and cough medicines to children
02 March 2009
Cephalon opens bid for Aussie bio-technology firm Arana
28 February 2009
Japan’s No.2 drugmaker Astellas makes $1-billion hostile bid for US firm CV Therapeutics
28 February 2009
US drug firm Cephalon makes $329 million offer for Australia's Arana
27 February 2009
Daiichi, Ranbaxy form team to face FDA charges
27 February 2009
Wockhardt to launch ulcer drug Ranitidine in the US
26 February 2009
Ranbaxy plant in India falsified data: US FDA
25 February 2009
Biogen in talks to acquire Acorda for multiple sclerosis pill
25 February 2009
Genentech tells shareholders to reject Roche bid
24 February 2009
Medtronic buys CoreValue, Ventor Technologies for $1.03 billion
24 February 2009
SC notice to Ramadoss on closure of public sector vaccine units
21 February 2009
Sale of Genentech skin drug `Raptiva' suspended after 3 deaths
20 February 2009
US, China in race for top slot in global wind industry
17 February 2009
Dutch minister promises a re-look at drug seizures on patent issues
11 February 2009
PPF ends opposition to Zentiva sale; Sanofi takeover likely
11 February 2009
Indian medicines made safer from patent piracy
10 February 2009
Medical world abuzz about cancer-killing CyberKnife
10 February 2009
Danish drugmaker Lundbeck to acquire Ovation of US for $900 million
09 February 2009
Piramal Healthcare denies reports of Glaxo, Sanofi bid
07 February 2009
Bird flu fears in China prompt extensive vaccination, closure of Hong Kong sanctuary
07 February 2009
Carl Icahn attempts to get nominees on Biogen board after blockbuster drug drags
07 February 2009
Government plans big push on generic drugs
06 February 2009
Glenmark receives approval from the US FDA for lithium carbonate capsules
05 February 2009
Schering-Plough’s quarterly results surpass expectations
04 February 2009
Study suggests insulin may be treatment for Alzeheimer's
03 February 2009
Troubled MDS may sell of divisions
03 February 2009
Pfizer discontinues global phase III trial of Axitinib for futility in advanced pancreatic cancer
31 January 2009
India, Brazil denounce seizure of medicines by Dutch authorities
31 January 2009
Amylin shares up as Icahn consolidates stake
31 January 2009
Roche lowers Genentech bid to $42 billion
30 January 2009
WHO shelves redefinintion amidst protest from Indian drug makers
27 January 2009
Pfizer-Wyeth create $68-billion blockbuster deal
27 January 2009
Glaxo buys UCB patents
24 January 2009
Stem cell study for spinal injury gets FDA nod
24 January 2009
Pfizer in talks to acquire Wyeth for $60 billion
23 January 2009
FDA woes hit Ranbaxy in Q4
23 January 2009
Unigene reports positive results on a novel peptide for reducing food consumption
21 January 2009
Ranbaxy affiliate Zenotech objects to open offer pricing
19 January 2009
India plans to move WTO as EU confiscates drugs in transit
16 January 2009
Eli Lilly to pay $1.42 billion to settle misdemeanor case regarding blockbuster drug Zyprexa
15 January 2009
Exact Sciences rebuffs Sequenom's $41 million buyout offer
13 January 2009
Abbott Laboratories acquires Advanced Medical Optics in $2.8 billion cash-and-debt deal
12 January 2009
American pharma major Wyeth looking to acquire Dutch vaccine maker Crucell
08 January 2009
Taro asks Sun to raise bid; proposes shareholder referendum
06 January 2009
Endo to acquire biopharma firm Indevus for $370 million
06 January 2009
Sun offers to buy Taro shares at a premium
05 January 2009
Daiichi Sankyo announces valuation loss for Ranbaxy acquisition of 359 billion yen
05 January 2009
Centre acquires controlling stake in 2 drug firms
02 January 2009
Pharma sales beat inflation
02 January 2009
American states receive million-dollar settlements from drugmaker Cephalon
31 December 2008
Amrutanjan to get makeover
26 December 2008
Piramal buys US-based Minrad to strengthen its position in anesthetics
24 December 2008
FDA warns consumers about tainted weight-loss products
23 December 2008
GlaxoSmithKline acquires Bristol-Myers Squibb Pakistan
22 December 2008
Aurobindo Pharma gets USFDA nod for anti-HIV drug
22 December 2008
Malvinder gets additional charge of chairman in reconstituted Ranbaxy board
20 December 2008
Wyeth acquires British biotech firm
19 December 2008
Infosys wins multi-million dollar AstraZeneca deal
15 December 2008
Pharmaceutical companies asked to pass excise benefits to consumers
15 December 2008
Bristol-Myers Squibb, Exelixis to collaborate on two novel cancer molecules
12 December 2008
Eli Lilly reports new product development on track
12 December 2008
Merck launches division for follow-on biotech drugs
11 December 2008
Pharma sector attracts Atlas Cycles and Shanku Group
06 December 2008
Research proves branded drugs not superior to generics
05 December 2008
Wockhardt gets US FDA approval for paediatrics drug
04 December 2008
Ranbaxy in pact to market BioPro's brain tumour drug in India
03 December 2008
Eli Lilly sues Lupin, Aurobindo for patent infringement
03 December 2008
J&J buys breast implant maker Mentor Corp for $1.07 billion
01 December 2008
Plethico to take 20 per cent stake in CIS drug maker
29 November 2008
Drugmaker Eli Lilly withdraws drug application to treat chronic pain
29 November 2008
Drug firms misusing patents to block cheaper generics: EU
28 November 2008
Sun Pharma's US arm acquires Chattem
27 November 2008
AstraZeneca, Abraxis rethink cancer drug deal
26 November 2008
Johnson & Johnson acquires Omrix Biopharmaceuticas for $465 million
25 November 2008
King Pharma to acquire Alpharma for around $1.6 billion
25 November 2008
Glenmark gets US FDA approval for marketing Ranitidine
21 November 2008
Sanofi settles Allegra, Nasacort patent suits with Teva, Barr
20 November 2008
AstraZeneca agrees to cut drug prices in UK, stock plummets
20 November 2008
Glenmark launches `Azathioprine' tablets in US
20 November 2008
Teva in bid to make generic version of Gilead's AIDS drug Truvada
15 November 2008
Wockhardt gets USFDA approval for insomnia drug sale
14 November 2008
US FDA observations not to affect drug sales: Lupin
14 November 2008
Zydus Cadila acquires Etna Biotech of Italy
11 November 2008
Glenmark starts selling pain killer drugs in US
10 November 2008
Sun Pharma extends offer for Taro till 19 December
10 November 2008
Amgen Positioned to Deliver Attractive Growth Over Next Five Years
08 November 2008
Daiichi Sankyo completes Ranbaxy acquisition
07 November 2008
Pfizer ends testing obesity drug on account of risk of US non-approval
06 November 2008
US Supreme Court split in Wyeth v/s Levine
05 November 2008
Genentech Submits application to US FDA for avastin for brain cancer treatment
04 November 2008
Sanofi's anti-obesity drug Acomplia pulled out of EU
25 October 2008
Exelixis says GSK drug research deal to end
24 October 2008
Eli Lily's suspension of arthritis drug development expected to hit Glenmark's pipeline
24 October 2008
Roche confirms plans to acquire remaining 44 per cent in Genentech
21 October 2008
Daiichi acquires 52.5 per cent in Ranbaxy
20 October 2008
Cadila gets USFDA approval antyi-depressant Risperidone
20 October 2008
Pfizer reaches $894 million settlement to resolve Bextra litigation
18 October 2008
Ranbaxy-Daiichi deal hits a regulatory bump
17 October 2008
Wockhardt gets US FDA nod to market Ceftazidime injections
16 October 2008
New anti-piracy law to be enacted in the US
15 October 2008
Abbott says its bioabsorbable drug-eluting stent could become next major breakthrough in interventional treatment
14 October 2008
Zydus Cadila receives WHO prequalification accreditation for Rabies vaccine
14 October 2008
Ipca Labs, US-based Heritage to market cardiovascular tablet, Propranolol in the US
13 October 2008
Ranbaxy-GSK submits IND application for respiratory inflammation candidate
13 October 2008
Chennai's Malladi Drugs to set up global hub in Malaysia
08 October 2008
Three scientists share Nobel prize for medicine
06 October 2008
Eli Lilly to acquire ImClone for $6.5 billion
06 October 2008
Jubilant in R&D, clinical trial joint venture with Eli Lilly
04 October 2008
Delayed approval of Ranbaxy deal brings $445 million windfall for Daiichi
04 October 2008
Mystery buyer Eli Lilly reported to outbid Bristol-Myers with $6.1 billion for ImClone
04 October 2008
Ely Lilly, Deciphera tie up for cancer drug research
03 October 2008
Advanced Life Sciences, Wyeth in Asian marketing pact for new drug
03 October 2008
US FDA probing deaths in German study involving J&J's anti-anemia drugs
03 October 2008
Emami woos Zandu shareholders by increasing offer price to Rs16,500
03 October 2008
Tata's Advinus Therapeutics, J&J arm in drug development pact
01 October 2008
Pharmaceutical offshoring to grow to Rs2,500 crore by 2012
29 September 2008
Orchid in pact with Merck & Co to develop novel anti-infective drugs
29 September 2008
Alpharma rejects King Pharmaceuticals’ $1.55 billion offer as inadequate
27 September 2008
Glenmark gets ANDA approval from US FDA for generic betamethasone corticosteroid
25 September 2008
Bristol-Myers Squibb raises bid for ImClone to $4.7 billion
23 September 2008
French pharma Sanofi-Aventis acquires Zentiva for $2.6 billion
23 September 2008
Ranbaxy hires New York ex-mayor Giuliani to resolve issues with US FDA
18 September 2008
Lupin acquires majority stake in South Africa's Pharma Dynamics
18 September 2008
US FDA bans import of over 30 Ranbaxy generic drugs
17 September 2008
Bayer acquires German biotech drug developer Direvo Biotech AG
16 September 2008
CSIR launches open source drug discovery
16 September 2008
Emami doubles offer price to Rs15,000 per Zandu share
15 September 2008
ImClone rejects Bristol-Myers Squibb's $4.3 billion bid; cites $6.1 billion fresh offer
10 September 2008
Essar Gujarat in petrochem technology licencing deal with CB&I
09 September 2008
Biocon says its oral insulin is good for Type 2 diabetes
08 September 2008
US FDA to list names of drugs under investigation
06 September 2008
Sun extends offer for Taro by a month as Israeli SC stays acquisition
04 September 2008
Maoists shut Dabur’s Nepal factory
04 September 2008
Japanese drug maker Shionogi to acquire American rival for $1.1 billion
02 September 2008
Fish oil better than AstraZeneca's Crestor says new heart-failure study
01 September 2008
Sun Pharma wins Taro takeover case in Israel
27 August 2008
Cabinet likely to clear Daiichi-Ranbaxy deal next month
26 August 2008
Lupin acquires stake in Australian pharma firm Generic Health
21 August 2008
Lupin in marketing alliance with Forest for asthma product
19 August 2008
Management expansion at McCann Healthcare Worldwide
19 August 2008
Methadone a double-edged painkiller
18 August 2008
Sun Pharma gets US regulator's approval for Taro open offer
14 August 2008
Orchid Pharma to make Merck's anti-coagulant drug
14 August 2008
Genentech rejects Roche’s $43.7-billion takeover offer as too low
13 August 2008
Australian pharma firm CSL buys US rival Talecris for $3.1 billion
13 August 2008
Dr Reddy's, Teva settle `carvedilol' patent dispute: report
12 August 2008
Panacea Biotec secures Rs143 crore UNICEF order for `EasyFive' vaccine
12 August 2008
Pfizer to settle Lipitor case with Canada's Apotex
11 August 2008
Finance ministry clears Daiichi-Ranbaxy deal among 24 FDI proposals
06 August 2008
Daiichi to launch open offer for Ranbaxy on 16 August
05 August 2008
Carl Icahn finds Bristol-Myers' offer for ImClone Systems low
04 August 2008
Orchid receives EU approvals for anti-bacterial injections Piperacillin, Tazobactam
04 August 2008
Bristol-Myers Squibb completes sell-off of ConvaTec to PE firms
04 August 2008
Ranbaxy applies for US FDA approval for Mohali plant; says WHO approves new ARV drug
02 August 2008
US FDA rejects Schering-Plough's post-surgery drug Sugammadex
01 August 2008
Bristol-Myers Squibb to acquire ImClone Systems for $4.5-billion
31 July 2008
Lupin Ltd, Sun Pharma and Dr Reddy's get US FDA approval for generic Depakote delayed-release tablets
31 July 2008
Sun set for a long battle for Taro
30 July 2008
Lupin enter Europe with acquisition of German pharma marketing agency Hormosan
30 July 2008
Ranbaxy banks on Pfizer settlement to revive falling fortunes
29 July 2008
After amlodipine in Japan, Ranbaxy launches omerprazole
28 July 2008
Agitators burn shed at Dow Chemical's construction site near Pune
26 July 2008
Roche bids for Genentech on Monday, acquires Mirus on Tuesday and Arius on Wednesday
25 July 2008
GlaxoSmithKline teams up with South Africa's Aspen to market branded generics
23 July 2008
Piramal Healthcare and Pierre Fabre launch French dermo cosmetic range in India
23 July 2008
US House representatives probe FDA approval of Ranbaxy drugs
23 July 2008
UK Crown court rejects charges against Ranbaxy
23 July 2008
Dr Reddy’s to buy back Perlecan Pharma stake from ICICI Ventures and Citigroup
22 July 2008
Bilcare Ltd, MeadWestVaco jointly acquire US pharmaceuticals packaging firm International Labs
21 July 2008
Sanofi-aventis to acquire Symbion Holdings for $544 million
21 July 2008
Roche makes a $43.7-billion bid for Genentech
21 July 2008
Clinton initiates cheap malaria drugs programme
19 July 2008
Biotechnology companies Genzyme and PTC Therapeutics ink $100 million deal
19 July 2008
No1 generic drugs maker Teva acquires rival Barr Pharma for $7.46 billion
18 July 2008
MNC rival trying to scuttle Daiichi deal: Ranbaxy
18 July 2008
Pakistan government blocks proposal to import Indian drugs
17 July 2008
FDA under probe as Ranbaxy says Daiichi deal is sealed
17 July 2008
Sun Pharma extends Taro tender offer
16 July 2008
Mark Mobius objects to Sun's acquisition of Taro
16 July 2008
Ranbaxy denies allegation of substandard drug sale; gets nod for stake sale
15 July 2008
Amgen to pay J&J's Ortho Biotech $200 million to settle suit
15 July 2008
Reports of coming under US FDA scanner hammer Ranbaxy stock
14 July 2008
India's first patent facilitation centre opens at Hyderabad
12 July 2008
Taro advises shareholders against Sun's open offer
11 July 2008
Novartis announces strategic partnership with Lonza to boost biologics pipeline
11 July 2008
Novartis to buy Swiss biotech company Speedel for $880 million
11 July 2008
Dr. Reddy's in global Ibuprofen marketing pact with Albemarle
09 July 2008
American drugmaker Eli Lilly buys biotech company SGX Pharma for $64 million
09 July 2008
Ahmedabad-based Veeda Oncology acquires International Oncology Network Clinical Research
08 July 2008
Fresenius to acquire APP Pharmaceuticals in $3.7-billion deal
07 July 2008
Ashok Kumar takes over as Secretary in the Department of Pharmaceuticals
07 July 2008
Panacea Biotec takes 75 per cent in Umkal to enter healthcare sector
05 July 2008
Cadila Healthcare to demerge consumer products division into Carnation, merge Zydus Hospitals with itself
05 July 2008
UK's Shire acquires maker of Firazyr, Jerini AG
04 July 2008
US court ruling helps AstraZeneca stave off Teva, Sandoz from 4$-billion Seroquel
03 July 2008
Piramal Healthcare acquires PlasmaSelect's polygeline product Haemaccel
03 July 2008
Glenmark acquires 7 pharmaceutical brands in Poland
02 July 2008
Exelixis and GlaxoSmithKline to conclude six-year discovery and development collaboration
28 June 2008
FDA bars use of Merck's cancer vaccine by women over 27
26 June 2008
Sun goes ahead with Taro acquisition; files suit in US court
26 June 2008
Tentative nod from USFDA for Ranbaxy's cancer drug valganciclovir
26 June 2008
US FDA delays approval on new drug by Eli Lilly and Daiichi Sankyo
25 June 2008
Zentiva turns down PPF subsidiary Anthiarose as Sanofi makes rival bid
23 June 2008
Johnson & Johnson Nordic AB acquires Åmic
23 June 2008
Taro sues Sun Pharma again; alleges plan to block sale of Irish arm
20 June 2008
Glenmark gets USFDA approval for anti-hypertensive, Trandolapril
20 June 2008
Top two shareholders, including Sanofi-Aventis, launch competing bids for Czech drugmaker Zentiva
19 June 2008
CNBC-TV18 shares with domain-b its exclusive interview with Malvinder Singh
18 June 2008
Pfizer and Ranbaxy settle global Lipitor patent litigation
18 June 2008
Cadila realigns consumer products division
18 June 2008
Boehringer Ingelheim to acquire Actimis Pharmaceuticals
18 June 2008
Daiichi to make open offer for Ranbaxy on August 8
16 June 2008
Bayer to make medicines from tobacco
16 June 2008
Sanofi commits 60 million doses of H5N1 vaccine for WHO global H5N1 vaccine stockpile
16 June 2008
Report on Pfizer move buoys Ranbaxy stock to a 3-year high
13 June 2008
Biotechnology giant Invitrogen plans to acquire peer Applied Biosystems for $6.7 billion
12 June 2008
Behind the Ranbaxy sale
12 June 2008
Glaxo to cut 350 R&D jobs in drug research revamp
11 June 2008
This is the start of a much larger game
11 June 2008
Ranbaxy struck deal at appropriate time: PwC
11 June 2008
Japan's Daiichi Sankyo to acquire majority stake in Ranbaxy
11 June 2008
Natco Pharma grants global marketing for its generic Copaxone to Mylan
10 June 2008
Taro selling Irish assets to thwart merger: Sun Pharma
06 June 2008
Biocon launches India's first pre-filled syringes
04 June 2008
Novartis buys US drug firm Protez for around $400 million
04 June 2008
Mylan Inc. acquires Merck KGaA's central eastern European generics businesses
02 June 2008
CuraGen presents encouraging results from ongoing Phase I / II study of CR011-vcMMAE in metastatic melanoma
02 June 2008
Emami buys 27.5 per cent in Zandu; to make open offer
31 May 2008
Bristol-Myers Squibb to buy anti-cancer drug maker Kosan Biosciences for $190 million
30 May 2008
Glenmark gets nod for marketing two drugs in US
30 May 2008
Zydus Cadila acquires Spanish drug firm Laboratories Combix
30 May 2008
Sun Pharma warns of legal action against Taro for stalling merger
29 May 2008
Israel's Taro to terminate merger with Sun Pharmaceutical
28 May 2008
Pharma firms threaten to stop production
28 May 2008
Alnylam in $1 billion RNAi drug research deal with Japan's Takeda
28 May 2008
Ranbaxy gets partial relief in `atorvastatin' case in Australia
28 May 2008
GVK BIO enters into drug discovery pact with Wyeth Pharmaceuticals
26 May 2008
Novo Nordisk seeks approval of new Type 2 diabetes drug in US, Europe
24 May 2008
Suven Life gets product patents in South Africa, China
20 May 2008
Zydus Cadila to market four products in the US after USFDA approval
16 May 2008
GlaxoSmithKline, Daiichi in hypertension drug deal in India
14 May 2008
Intercell to acquire Iomai Corporation for $189 million
13 May 2008
Ranbaxy to develop new drugs for Merck & Co
10 May 2008
Johnson & Johnson patent lawsuit agains Boston Scientific's NIR stent dismissed in Canada
09 May 2008
Jubilant Organosys acquires Speciality Molecules for about Rs20 crore
08 May 2008
Enzon Pharma to spin off biotechnology business
08 May 2008
Novo Nordisk researchers nominated for Europe’s top innovation prize for new version of insulin
06 May 2008
GSK Pharma signs licensing agreement with Astellas of Japan
05 May 2008
Indian vultures face extinction due to diclofenac poisoning
05 May 2008
Divested from Pfizer, Esperion Therapeutics completes $22.75-million series A financing
03 May 2008
Bristol-Myers Squibb sells ConvaTec to PE firms for $4.1 billion
03 May 2008
Merck extends enrollment deadline for US Vioxx product liability lawsuit claimants
03 May 2008
Teams unravel heparin death mystery
02 May 2008
Dr Reddy's acquires BASF's contract manufacturing business in US
30 April 2008
Novartis Research announces breakthrough in restoring light sensitivity in damaged retinas
29 April 2008
US FDA turns down Merck's ER niacin / laropiprant
29 April 2008
Ranbaxy gets a boost as US patent office rejects Pfizer's Liptor plea
28 April 2008
Brazil declares anti-AIDS drug to be of public interest; India's pharma industry may benefit
28 April 2008
Pfizer forms diabetes, obesity research consortium with universities
26 April 2008
Government brings 1,421 drugs under Price Control Order
25 April 2008
GlaxoSmithKline acquires Sirtris Pharmaceuticals
24 April 2008
Delhi HC upholds ruling in Cipla-Roche cancer drug row
23 April 2008
Ranbaxy forces Orchid into an alliance
22 April 2008
Dabur Pharma to sell majority stake to Singapore-based Fresenius Kabi Pte Ltd
19 April 2008
Nicholas Piramal buys two Khandelwal Laboratories brands for Rs116 crore
16 April 2008
Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US
15 April 2008
Why Ranbaxy fancies Orchid
14 April 2008
Ranbaxy group closer to 15 per cent stake in Orchid
14 April 2008
Ranbaxy's Solrex picks up 1 per cent more in Orchid Chemicals
11 April 2008
Japan's Takeda to acquire Millennium Pharma for $8.8 billion
10 April 2008
Glenmark's Swiss arm completes Phase I trials for monoclonal antibody GBR 500
10 April 2008
Orchid Chemicals announces Japanese subsidiary
10 April 2008
Orchid Chemicals stock surges as Ranbaxy group hikes stake
08 April 2008
Ranbaxy receives Japanese authorisation for product development outside Japan
08 April 2008
Dr Reddy's acquires Jet Generici Srl; to establish generics range in Italy
03 April 2008
Ranbaxy introduces world's first biogeneric injectible drug for osteoporosis
03 April 2008
Teva to acquire Bentley Pharmaceuticals
01 April 2008
Dr Reddy's to buy two Dowpharma Small Molecules units in the UK
01 April 2008
Indian Pharma Industry should make 40 per cent of the world's generic drugs: APJ Abdul Kalam
31 March 2008
Aurobindo acquires Italian generic pharma firm TAD
24 March 2008
Wockhardt says derivative losses not to affect Q1 performance
24 March 2008
Cipla to continue selling its version of Roche's lung cancer treatment drug
20 March 2008
Japan's biggest drug maker to expand in the US
20 March 2008
Sun Pharma gets US FDA approval to market generic Cerebyx
20 March 2008
Ranbaxy to introduce dental drug Inersan in India, Nepal
18 March 2008
USFDA approves Sun Pharmaceutical's generic cancer drug Ethyol in US markets
17 March 2008
Glenmark Pharmaceuticals launches Clobetasol from its niche dermatology pipeline
17 March 2008
SC refuses to stay Gujarat HC order on Ranbaxy's 'Volini' ad
12 March 2008
Suven Life signs another drug research pact with Eli Lilly
12 March 2008
Dr Reddy's Laboratories and 7TM Pharma sign drug research pact
10 March 2008
USFDA grants tentative approval to Sun Pharma's generic anti-cancer injection Gemzar
07 March 2008
Pfizer to acquire Serenex, extend oncology pipeline
05 March 2008
Drug Controller approves Venus Remedies' latest antibiotic drug
04 March 2008
Drugs to become cheaper: Ram Vilas Paswan
01 March 2008
Dabur launches injection for cancer treatment in US
29 February 2008
Baxter withdraws heparin blood thinners made from Chinese supplies
29 February 2008
Matrix Labs may divest Docpharma
28 February 2008
Shasun Chemicals technology licenses API technology to Merck
27 February 2008
New Novartis Research Institute first to focus on innovative vaccines for the developing world
23 February 2008
Nicholas Piramal Research in India's first public-private drug research project
22 February 2008
Sun Pharmaceutical buys Taro Pharma shares from Brandes
20 February 2008
Ranbaxy board approves de-merger of new drug discovery research unit in to Ranbaxy Life Science Research Ltd
19 February 2008
AstraZeneca forms clinical research venture with private equity firms
18 February 2008
Zydus Cadila launches new drug for cancer therapy
15 February 2008
Nicholas Piramal R&D arm in $110-million new drug deal with Eli Lilly
15 February 2008
Patent expiries destabilise global pharmaceutical majors, says Datamonitor research
14 February 2008
Wockhardt's Azithromycin to battle Pfizer's Zithromax in the US market
13 February 2008
Bayer HealthCare affiliate MEDRAD to acquire devises maker Possis Medical
12 February 2008
Strides Arcolab acquires 17.7-per cent stake in Genepharm Australasia
08 February 2008
Alpharma divests API business to 3i for $395 million
07 February 2008
Nicholas Piramal launches hypertension product
07 February 2008
USFDA grants tentative approval to Ranbaxy's esomeprazole magnesium DR capsules in the US
07 February 2008
Glenmark receives milestone payment from Forest Labs for phase II study on Oglemilat
06 February 2008
US FDA approves Ranbaxy's generic version of GlaxoSmithKline's Ceftin for US sales
06 February 2008
DiaGenic announces preliminary results from Indian breast cancer study
05 February 2008
Amgen and Takeda announce exclusive collaboration in Japan on up to 13 Amgen clinical candidates
04 February 2008
US FDA grants tentative approval to Teva's generic Flomax capsules
01 February 2008
Sun Pharma launches generic version of Wyeth's Protonix
30 January 2008
Shasun Chemicals to set up new facilities in N. America
28 January 2008
US FDA approves Glenmark Pharmaceuticals Baddi semi-solids plant
28 January 2008
Matrix Laboratories hikes stake in China's Mchem to 97 per cent
25 January 2008
Novo Nordisk divests three metabolic-disorder treatment programmes to TransTech Pharma
25 January 2008
Anti-smoking vaccines set to help millions; to boost prescription market
25 January 2008
Zydus Cadila to collaborate with US-based Prolong Pharmaceuticals for drug discovery
24 January 2008
Roche to acquire Ventana for $89.50 per share
23 January 2008
Teva to acquire CoGenesys
23 January 2008
Nicholas Piramal buys Healthline's pharmaceuticals business
23 January 2008
Suven Life Sciences receives second US patent
23 January 2008
Ranbaxy announces settlement of possible Imitrex litigation with Glaxosmithkline
21 January 2008
Dr Reddy's announces settlement of Exelon (rivastigmine tartrate ) ANDA litigation with Novartis
21 January 2008
Wockhardt to demerge R&D business
18 January 2008
Pfizer-funded study reports reduction in heart attacks by adding Lipitor early to blood pressure treatment
18 January 2008
India asks Indonesia to remove non-tariff barriers on Indian pharma products
18 January 2008
WHO grants international non-proprietary name Melogliptin to Glenmark Pharmaceuticals's anti-diabetic drug
14 January 2008
Ranbaxy enters Chyawanprash market with suger-free `Chyawan Active'
11 January 2008
US wants to open FDA office in India
11 January 2008
Strides Arcolab discontinues manufacturing operations in New Jersey
09 January 2008
Genzyme and Isis announce strategic alliance including exclusive worldwide license of Mipomersen
08 January 2008
Marksans Pharma acquires UK’s Hale Group Ltd, owner of Bell, Sons & Co
07 January 2008
Panacea Biotec pre-qualified by WHO to supply children's immunisation drug
05 January 2008
National Pharmaceutical Pricing Authority seeks cost data from pharmaceutical industry
04 January 2008
Cephalon seeks second use for chemo drug
03 January 2008
Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US
02 January 2008
Suven Life Sciences receives first product patent in the US
27 December 2007
Aurobindo Pharma gets US approval to sell generic Omnicef
19 December 2007
Nicholas Piramal in JV with Japan's Arkray to market blood glucose monitoring products
19 December 2007
Health minister to release Indian Pharmacopoeia 2007
17 December 2007
Novartis plans to cut 22,00 jobs worldwide
13 December 2007
Drug prices fixed under DPCO 1995 have to be compulsorily implemented: Government
11 December 2007
Nicholas Piramal's cyclin-dependent kinase inhibitors granted US product patent
11 December 2007
Eli Lilly predicts higher 2008 profit; to launch new products by 2011
07 December 2007
Bristol-Myers Squibb will cut jobs, close plants, to save $1.5 billion
07 December 2007
US FDA panel rejects the use of Genentech’s Avastin for breast cancer
07 December 2007
Sun Pharma announces settlement of litigation over generic Exelon
06 December 2007
Matrix Labs gets US FDA nod for HIV drug
05 December 2007
Abbott Labs cuts 1,200 jobs as drug-coated heart stent market shrinks
05 December 2007
French drug giant Sanofi-Aventis opens R&D centre in Goa
05 December 2007
Pfizer to outsource 30 per cent of manufacturing to Asia, cut 10,000 jobs
04 December 2007
Bristol-Myers Squibb likely to cut 4,300 jobs
01 December 2007
Astellas acquiring cancer biotech firm Agensys
27 November 2007
Aurobindo Pharma receives five product approvals from USFDA including two Paragraph IV products
24 November 2007
Nicholas Piramal in R&D collaboration with Merck & Co
19 November 2007
Pfizer to acquire Coley Pharmaceutical for $164 million
19 November 2007
US FDA approval Orchid's ANDA for Cefpodoxime Proxetil
17 November 2007
Dr Reddy's gets US FDA nod for marketing Ciprofloxacin
17 November 2007
Glenmark Pharma to spin off generics unit, list new unit next year
17 November 2007
Merck agrees to settle Vioxx claims for $4.85 billion
15 November 2007
GSK to launch cancer drug Tykerb in India
10 November 2007
Contract research firm Manipal AcuNova acquires Germany''s ECRON
05 November 2007
Pfizer to license Taisho Pharmaceutical''s schizophrenia drug candidate TS-032
01 November 2007
Biocon plans Rs 100 crore annual research spend
31 October 2007
Ranbaxy wins patent case against Pfizer cholestrol drug Liptor in Germany
30 October 2007
US state Utah seeks co-operation with India in life science research
30 October 2007
Glenmark signs up marketing deal with MyerZall Labs
27 October 2007
Sigma-Aldrich, Oxford BioMedica win key ruling in Open Biosystems patent infringement dispute
26 October 2007
Glenmark and MeyerZall Laboratories to offers topical dermatology products in South Africa
25 October 2007
Suven Life Sciences, University of Minnesota to develop drugs jointly to treat HIV
25 October 2007
Ranbaxy launches Osonase nasal spray in India
25 October 2007
Wockhardt acquires US pharma firm Morton Grove Pharmaceuticals
24 October 2007
Dabur enters supply and distribution agreement with Combino Pharm
24 October 2007
US FDA approves Sun Pharmaceutical''s Novartis-equivalent generic Exelon capsules for US markets
24 October 2007
Researchers see role for `septins'' in treatment of Alzheimer''s, Parkinson''s
20 October 2007
Medical Retail chain Medicine Shoppe to expand network outside Mumbai
19 October 2007
USV in marketing tie-up with Germany''s Sebapharma
19 October 2007
Drug Controller-General approves Biocon - Abraxis BioScience breast cancer drug Abraxane
19 October 2007
Himalaya Drug Company to expand retail presence
19 October 2007
Ranbaxy follows Sun Pharma in demerging R&D business
19 October 2007
Ranbaxy plans to spin off research arm as Q3 net profit zooms 48 per cent
18 October 2007
Panjab University and Panacea Biotec to develop new chemical entities
10 October 2007
Government plans central authority for drug licensing
08 October 2007
Avesthagen-Cipla JV acquires Siegfried Biologics in Germany
05 October 2007
Accenture and Bristol-Myers Squibb launch pharmaceutical industry''s first joint centre for pharmacovigilance
14 September 2007
Toray develops Hepatitis C vaccine
28 August 2007
Matrix to acquire residual holding in China''s Mchem group
25 August 2007
No data on of siphoning of funds by pharmaceutical companies: Minister
24 August 2007
Roche secures US court injunction for its Ventana bid
23 August 2007
Boston Scientific to explores divestment of surgical products unit
18 August 2007
Ranbaxy could gain as Pfizer loses initial bid for Lipitor patent extension
17 August 2007
Ajanta Pharma out licences formulation technology to Taiwan''s Orient Europharma
16 August 2007
Ipca-Ranbaxy alliance to market Metformin HCL tablets in US
14 August 2007
Unigene Laboratories acquires exclusive licence for therapies from University of London
10 August 2007
Lupin to invest Rs200 crore in new plant, capacity addition
10 August 2007
Biocon in pact with Abraxis to market breast cancer drug Abraxane in India
09 August 2007
Switzerland not to take Novartis case before WTO
08 August 2007
Patent tussle fallout: MNCs may turn cautious on India
07 August 2007
Bayer HealthCare and Nektar Therapeutics to develop innovative therapy for pneumonia
06 August 2007
Strides Arcolab completes acquisition of Diaspa''s fermentation facility in Italy
06 August 2007
Chennai court rejects Novartis patent challenge
06 August 2007
KKR Boots' debt may devolve on underwriters
04 August 2007
Dr Reddy's and Rheoscience commence Phase III diabetes drug trials
02 August 2007
Genstar makes another grab for PRA
31 July 2007
Merck buys cardiac biotech start-up NovaCardia
31 July 2007
Ranbaxy to sell authorised generics product Isoptin SR in US
30 July 2007
Indonesia bans cosmetics, medicine and food from China
30 July 2007
Biocon enters into JV with Neopharma of UAE
30 July 2007
Genstar to acquire contract drug manufacturer PRA for second time
28 July 2007
SNC-Lavalin acquires pharma engineering firm Pipecon
27 July 2007
Merck to acquire NovaCardia for $350 million
27 July 2007
Aventis group firm acquires diabetes drug technology from Themis
26 July 2007
Ranbaxy, GSK to settle valacyclovir patent case in US
26 July 2007
Elder Pharma to acquire 20 per cent stake in UK's Neutra Health
26 July 2007
GlaxoSmithKline pharmaceuticals divests fine
26 July 2007
Significant opportunities for Ranbaxy from GlaxoSmithKline deal: Malvinder Singh
26 July 2007
Neutra Health acquisition to facilitate entry into regulated markets: Elder Pharma
26 July 2007
Nicholas Piramal''s new drug IND-P276 approved by US FDA
25 July 2007
Teleflex avquires medical products maker Arrow for $2 billion
25 July 2007
China asks tainted food and drug firms to shut down
23 July 2007
Swedish pharma firm Meda to acquire Medpointe
23 July 2007
Purdue Pharma fined $634 million for OxyContin deaths; executives punished
22 July 2007
Court revives shareholder lawsuits over Vioxx against Merck
20 July 2007
Glenmark acquires rights to two therapeutic antibodies from Chromos
19 July 2007
Abraxis BioScience to license biosynthetic cancer drug from Biocon
19 July 2007
Lupin gets DCGI nod for phase II and III clinical trials of herbal psoriasis drug
19 July 2007
Orchid Chem to launch three new products in the US
18 July 2007
World Bank blacklist two Indian pharma companies for ''collusive'' practices
17 July 2007
Rebuffed by Ventana, Roche may increase its $3-billion bid
13 July 2007
Dishman Pharma to acquire Solvay's Dutch fine chemicals unit
09 July 2007
Novartis AG receives first worldwide approval in US for Alzheimer''s patch
09 July 2007
Roche goes to court over Ventana''s poison-pill defence
05 July 2007
Roche makes hostile offer for Ventana
27 June 2007
Roche buys Toyama''s arthritis drug for $370 million
26 June 2007
Ranbaxy to benefit from 180-day US market exclusivity for its pravastatin
25 June 2007
Zydus Cadila acquires Brazilian company Nikkho
25 June 2007
China slaps anti-dumping duty on antibiotic from India
16 June 2007
US panel blocks Sanofi''s weight-loss drug
16 June 2007
Dr Reddy's commences operations in Nigeria
16 June 2007
Rising disease may take India to top 10 pharma markets by 2020
13 June 2007
Aurobindo Pharma rules out stake sale
13 June 2007
Strides Arcolab acquires Grandix for Rs100 cr
12 June 2007
Nicholas Piramal in tie-up for cancer, diabetes research
11 June 2007
Nigeria sues Pfizer for illegal drug trials, claims $7 billion in damages
05 June 2007
Strides Arcolab to buy Italian Diaspa''s drug unit
29 May 2007
Ranbaxy buys 13 dermatology brands from Bristol-Myers
28 May 2007
Alembic enters into licensing pact with Belgian co
24 May 2007
Indian pharma to grow big in few years
24 May 2007
NPPA strikes drug firms for raising MRP
24 May 2007
Sun Pharmaceutical to acquire Taro Pharma for $454 million
21 May 2007
Lupin receives tentative US FDA approval for anti-psychotic drug Ziprasidone
21 May 2007
Dr Reddy's is setting up two SEZs
19 May 2007
Glenmark receives US FDA approval for cardiac and NSAIDs generics
16 May 2007
Mylan Laboratories to acquire Merck generics unit for $6.6 billion
14 May 2007
FDA panel seeks curbs on Amgen, J&J anaemia drugs
11 May 2007
FDA fines US drug firm $634m over painkiller misleads
11 May 2007
Dabur Pharma sets up US subsidiary
09 May 2007
Wockhardt acquires France`s Negma Labs for Rs1,090 crore
03 May 2007
Internal accruals to fund Negma acquisition: Khorakiwala
03 May 2007
AstraZeneca to acquire US biotech firm MedImmune for $15.6 billion
28 April 2007
Jubilant Organosys acquires Hollister-Stier of US for $122.5 million
26 April 2007
KKR-Pessina combine to buy Alliance Boots for $22.2 billion
25 April 2007
US FDA approves Ranbaxy''s pravastatin sodium tablets
25 April 2007
Wockhardt to launch Italy''s B-Lift range of dermatology products in India
23 April 2007
Zydus Cadila acquires Nippon Universal of Japan 19 April 2007
19 April 2007
Wockhardt to introduce treatment for dermatological scars
17 April 2007
Nestle to acquire Gerber for $5.5 billion; eyes US expansion
12 April 2007
Lupin gets USFDA approval for paediatric Suprax oral suspension
12 April 2007
Bidding battle expected for Boots
10 April 2007
Government warns Novartis of compulsory licensing
10 April 2007
Orchid enters Canadian market with two generic formulations
10 April 2007
Ranbaxy Labs acquires 14.9-per cent stake in Jupiter Bio Science
07 April 2007
Lupin sells part rights of 'perindopril' to French firm for Rs115 crore
07 April 2007
India court reserves order in Novartis patent case
05 April 2007
Terapia Ranbaxy receives 3-year GMP certification renewal for Bucharest facility
04 April 2007
Ranbaxy-GSK alliance to develop respiratory drug
02 April 2007
Eli Lilly sues Sun Pharma over patent for cancer drug
02 April 2007
Novartis slumps after pulling Zelnorm
31 March 2007
Alliance Boots gets revised $20 billion offer from KKR, Pessina
31 March 2007
Ranbaxy launches asthma drug 'Osovair' in India
30 March 2007
Strides Arcolab gets tentative US FDA nod for AIDS drug
29 March 2007
Glenmark confirms filing ANDA with ''paragraph IV certification'' for Zetia tablets
28 March 2007
Wockhardt receives US FDA approval for diuretic injection
28 March 2007
Government to enforce 5-per cent cut in prices of 75 drugs
27 March 2007
Glenmark acquires Czech firm Medicamanta
26 March 2007
Is Torrent a serious contender for Merck?
23 March 2007
Opportunities for India in generic drug space
21 March 2007
Ranbaxy withdraws bid for Merck's generic business
20 March 2007
Zydus Cadila acquires Liva Healthcare
17 March 2007
Ranbaxy enters second round of bidding for Merck unit: report
16 March 2007
Ranbaxy gets USFDA nod for zolpidem tablet production in US
16 March 2007
Biocon arm to set up dedicated R&D facility for Bristol-Myers Squibb
14 March 2007
Strides Arcolab receives US FDA approvals for two new drugs
14 March 2007
Boots rejects KKR's £9.7 billion offer as being low
13 March 2007
Lupin gets marketing approval for cefpodoxime proxetil in France
13 March 2007
Akzo Nobel sells Organon BioSciences to Schering-Plough for €11 billion
13 March 2007
Ranbaxy Laboratories Bids for Merck''s Generic Unit
13 March 2007
Merck suffers adverse Vioxx lawsuit in the US
13 March 2007
Boots to consider KKR's £9.7 billion offer
12 March 2007
Glenmark in funded research agreement with Swiss firm Dyax
12 March 2007
After acquiring Schering, Bayer to cut 6,100 jobs worldwide
03 March 2007
US firm acquires global rights for anti-cholestrol drug from Ranbaxy
01 March 2007
Ranbaxy plans ADS offering to finance Merck arm acquisition
21 February 2007
Biocon to invest Rs 1,000 crore in Vizag SEZ
17 February 2007
ADAG to rewrite drug distribution rules
10 February 2007
Ranbaxy enters biosimilar product space with Zenotech, targets EU markets
08 February 2007
Ranbaxy-Glaxo extend pact
07 February 2007
Pfizer loses battle for Chinese name for Viagra
06 February 2007
Dr Reddy's to join the race for Merck's generic business
05 February 2007
Glaxo moves court against Ranbaxy''s generic drug
03 February 2007
Wyeth sued over Zosyn patent
03 February 2007
Global collaboration to develop new anti-obesity compounds
02 February 2007
Pfizer wins Norvasc patent case against Synthon
02 February 2007
Ranbaxy launches two NDDS Urology products in India
30 January 2007
Novartis patent case a threat to developing nations: Medecins Sans Frontieres
30 January 2007
Sun Pharma to acquire companies in the US
24 January 2007
Pfizer to retrench 8,000
22 January 2007
US move to prevent restrictions on generic drugs
18 January 2007
Biocon grants marketing license for cancer drug in Pakistan
18 January 2007
Ranbaxy pitted against Texas Pacific, Cinven, Permira for Merck''s generic-drug unit
12 January 2007
Organon Biosciences in biopharma development deal with China's Huya Bioscience
10 January 2007
Mylan completes stake acquisition in Matrix
10 January 2007
Ranbaxy to bid over $5 billion for Merck Generics
09 January 2007
Suven Life Sciences Secures Patent
09 January 2007
Only 12 per cent of drugs market to be under price control
08 January 2007
Biocon in joint venture with Abu Dhabi-based Neopharma
06 January 2007
Chemists body in TN plans distribution firm
05 January 2007
Dabur launches new delivery system for anti-cancer drug
04 January 2007
Ipca - Ranbaxy alliance receive US FDA marketing approval for atenolol tablets
02 January 2007
Lupin awarded tentative US FDA approval for sertraline
02 January 2007
Aurobindo Pharma acquires Dutch company
30 December 2006
Ipca's 'Atenolol' bulk drug registered in China
29 December 2006
Wockhardt, Dr Reddy's launch generic Ondansetron in the US
27 December 2006
Biocon subsidiary Clinigene completes phase-IV study on new generation insulin
26 December 2006
Iceland''s Actavis acquires manufacturing plant in Chennai
22 December 2006
Aurobindo receives approval for AIDS drug
22 December 2006
Reliance Life Sciences to acquire UK's GeneMedix
22 December 2006
Why is RLS interested in GeneMedix?
22 December 2006
Ranbaxy wins Lipitor patent against Pfizer in Australia
21 December 2006
Eli Lilly accused of concealing health risks of Zyprexa
19 December 2006
Glaxo buys Genmab's leukemia drug for record $2.1 billion
19 December 2006
Ranbaxy, department of science and technology to jointly develop new drugs
18 December 2006
Ayurvedic mouthwash to relieve radiation pain in cancer patients
16 December 2006
Nestle acquires Novartis nutrition food unit for $2.5 billion
15 December 2006
Ranbaxy gets USFDA approval for Cefprozil anti-infective tablets
15 December 2006
Glenmark to start clinical trials of painkiller in Europe
14 December 2006
J&J's acquisition of Pfizer Healthcare passes anti monopoly scrutiny
13 December 2006
Forest''s Lexapro tops anti-depresant drug trial
08 December 2006
Akorn-Strides JV takes product pipeline to 29 ANDAs
07 December 2006
Dabur Pharma gets US FDA approval for cancer drug
07 December 2006
Glenmark signs an additional deal for seven ANDAs with LVT
07 December 2006
Panacea signs joint venture pact with Cambridge Biostability of UK
06 December 2006
Pfizer aborts cholesterol drug tests
04 December 2006
Ranbaxy acquires South Africa's fifth largest generics company
01 December 2006
Dr Reddy's to raise Rs 1,027 crore through additional ADS issue
30 November 2006
Torrent in pact with DRL to market Listril and Listril Plus in Russia
29 November 2006
FDA orders withdrawal of Wockhardt's insulin brand 'Wosulin'
25 November 2006
Nicholas Piramal signs collaboration pact with BioSyntech
17 November 2006
Glenmark develops API for Napo''s phase III diarrhoea drug trials by US
17 November 2006
Tata Group''s Advinus to develop metabolic drugs for Merck
16 November 2006
US Court''s Zocor verdict to benefit Ranbaxy and Dr Reddy''s
15 November 2006
Zydus Cadila files novel drug candidate for obesity disorders
14 November 2006
Abbott''s Kos acquisition driven by growth in cholesterol market
09 November 2006
Merieux Alliance acquires majority stake in Shantha Biotechnics
09 November 2006
Panacea Biotec's R&D centre gets government recognition
07 November 2006
Drug makers turn from blockbusters to ''niche-busters'' for future growth
03 November 2006
Government reduces dealer margins on 886 medicines
31 October 2006
Orchid to help Swedish drug major in drug research
30 October 2006
Nicholas Piramal signs R&D licensing agreements with UK''s Morvus Technology
27 October 2006
Ranbaxy to introduce Debiopharm's gastro drug in India
23 October 2006
New Drugs Act: What''s in store for Indian drug industry?
19 October 2006
Claris Life Sciences to expand capacity and product portfolio
13 October 2006
Granules India forms joint venture with Chinese company
12 October 2006
Step towards full backward integration with supply chain says Granules MD
12 October 2006
Torrent signs in-licensing deal to market Chinese cardiac blockbuster
11 October 2006
Dr Reddy's to get generic rights as Glaxo settles Imitrex patent row
10 October 2006
IPCA phases out single ingredient malarial drug; launches India's first ACT
06 October 2006
Pfizer still biggest player in highly prized indication: Datamonitor
06 October 2006
US FDA approves Aurobindo Pharma''s Meloxicam for US sales
06 October 2006
Wockhardt acquires Pinewood for $150 million, fourth European acquisition
03 October 2006
Nicholas Piramal acquires Boots Piramal Healthcare
03 October 2006
Dr Reddy’s, ClinTec International announce co-development of anti-cancer compound
28 September 2006
Dr Reddy's opens manufacturing facility at Visakhapatnam
26 September 2006
Sterling Bio to acquire gelatin company in China
26 September 2006
JB Chemicals, Matrix Labs in licensing agreement with Gilead Sciences for HIV drug
22 September 2006
Germany''s Merck acquires Europe''s largest biotech company
21 September 2006
Orchid's formulation and API facilities approved by UK MHRA
21 September 2006
Ipca Laboratories in marketing alliance with Ranbaxy for US sales
21 September 2006
US FDA approves Ranbaxy's sale of furosemide in the US
21 September 2006
German Remedies launches third-generation inhaler for asthamatics
20 September 2006
Biocon launches cancer anti-body drug BioMab-EGFR
18 September 2006
Ranbaxy to market Ethypharm's cardiovascular drug in India
18 September 2006
Fifth volume of Ayurveda Pharmacopoeia released
18 September 2006
Dr Reddy's acquires Spain's Litaphar: CNBC
18 September 2006
Wockhardt to develop SEZ near Aurangabad for its global biopharma hub
18 September 2006
Is pharma retailing the next big opportunity?
13 September 2006
Wockhardt close to acquiring Pinewood: CNBC
13 September 2006
Ranbaxy receives US FDA nod to market loperamide hydrochloride and simethicone tablets
11 September 2006
Government to grant limited period protection for new drugs
05 September 2006
Biocon's Syngene International and Sweden's Innate Pharma to develop virulence blockers
04 September 2006
Strides Arcolab to acquire drug unit in Singapore
01 September 2006
Wockhardt's Cefotaxime injection receives US FDA approval
31 August 2006
India to host Asia biotech meet
30 August 2006
Ranbaxy wins two additional atorvastatin patents in Norway
30 August 2006
Aurobindo betalactum facility receives MCC South Africa's approval
28 August 2006
Update: Generic API biz to strengthen post deal says Matrix Labs CEO
28 August 2006
Mylan Labs to acquire Matrix Labs for $736 million
28 August 2006
Mid Pharma looks outside itself to drive revenue: Datamonitor
26 August 2006
TAKE Solutions wins Dabur Pharma order
24 August 2006
Dishman Pharmaceuticals acquires Carbogen AMC1S from Solutia
23 August 2006
GSK withdraws patent plea for AIDS drug Combivir
21 August 2006
Unbranded drugs may get cheaper by 50-60 per cent
18 August 2006
Aurobindo gets marketing approval for mirtazapine tablets in UK
18 August 2006
Expect Tazobactum approval by June 07: Orchid Chem
16 August 2006
Suven completes pre-clinical trials of new drug molecule
16 August 2006
Aurobindo gets second MHRA approval in UK for mirtazapine tablets
09 August 2006
Panacea Biotec granted patent for 'controlled release' nimesulide composition
07 August 2006
Ranbaxy receives tentative US FDA approval to market Risperidone oral solution
05 August 2006
Glenmark gets DCGI nod for Phase II trials of diarrhoea drug
03 August 2006
Mixed victory for Ranbaxy in patent row with Pfizer
03 August 2006
Orchid to acquire 100 per cent in US drug discovery unit Bexel
01 August 2006
Orchid Chemicals hosts presidential visit at its formulations complex
31 July 2006
Hope to maintain margins at 15 per cent: JB Chemicals
29 July 2006
US FDA approves drug to treat rare genetic disease
25 July 2006
Lupin gets US FDA approval for Meloxicam
20 July 2006
Gates Foundation to fund collaborative research for HIV vaccine
20 July 2006
Ranbaxy acquires GlaxoSmithKline subsidiary Mundogen in Spain
18 July 2006
ReAble to acquire DJO for $1.6 billion
18 July 2006
Panacea opens new Baddi facility and office in Mumbai
17 July 2006
Glenmark, Merck''s Generics in derma products pact in the UK
17 July 2006
Panacea to market PT Bio's measles vaccine
12 July 2006
Aurobindo receives US FDA approval for 3-in-1 ARV combination
03 July 2006
Welspun acquires UK''s top towel brand, Christy
03 July 2006
New Genentech eye drug gets FDA approval
01 July 2006
Ranbaxy's 'Cefprozil' gets US FDA approval
01 July 2006
Bayer divests diagnostics to Siemens, eases impact of Schering acquisition
30 June 2006
Wockhardt acquires Dumex with Protinex, Farex brands from Royal Numico NV
30 June 2006
GE ties up with Manipal Hospital for clinical trials
29 June 2006
U K appeals court affirms HC ruling in Ranbaxy-Pfizer case
28 June 2006
J&J to acquire Pfizer Consumer Healthcare for $16.6 billion
26 June 2006
Wockhardt UK expanding Byetta manufacturing capacity
16 June 2006
Nicholas Piramal to acquire Pfizer''s UK Facility
15 June 2006
Croatian drug firm Pliva opens research facility in India
14 June 2006
Wockhardt gets US FDA approval for anti-epilepsy drug
14 June 2006
Merck & Co develops new diabetes drug
14 June 2006
Paul Royalty to finance drug development by Glenmark
05 June 2006
Wockhardt in-licenses dermatology drug from LSI of UK
05 June 2006
Wockhardt receives US FDA approval for clarithromycin tablets
01 June 2006
Zydus Cadila receives US FDA approval to market Warfarin in the US
01 June 2006
Lupin to acquire 51-per cent stake in Dafra
25 May 2006
Dishman to acquire Solutia's pharmaceutical services business
24 May 2006
Lupin gets US FDA approval for Cefdinir
24 May 2006
Dr Reddy's launches oral bronchodilator for asthma, COPD
16 May 2006
US FDA approves Wockhardt's Waluj plant
11 May 2006
Roche reports strong global sales for Tamiflu
27 April 2006
Biocon Biopharmaceuticals’ new biologics facility
17 April 2006
Dr Reddy's receives US FDA approval for fexofenadine hydrochloride
13 April 2006
Pharmacies gear-up to ride the retail boom
12 April 2006
Glenmark, is India''s first pharma company to implement ''structured product labeling''
31 March 2006
Pfizer India Q1 net jumps 84 per cent
29 March 2006
Ranbaxy to acquire Glaxo's generic business in Italy
28 March 2006
Ind Swift Laboratories API facility gets TGA certification
22 March 2006
Dr Reddy's in discussions with Sanofi-Aventis to settle Plavix litigation
22 March 2006
Ranbaxy acquires patent & rights for auto-injector device
21 March 2006
Zydus Cadila to commence phase II clinical trials on ZYH1
20 March 2006
Bristol-Myers grants ARV license for two drugs to Aurobindo Pharma
17 March 2006
Aurobindo receives first NDA approval for HIV-1 drug from US FDA
16 March 2006
Update: US FDA nod for Aurobindo''s Lisinopril & Hydrochlorothiazide tabs
16 March 2006
Ranbaxy Laboratories ties-up with Zenotech to market cancer injectibles
09 March 2006
Aurobindo Pharma receives final US FDA approval for Mirtazapine ODT 45mg
02 March 2006
Wockhardt receives US FDA approval for Ranitidine OTC version
27 February 2006
Setback for Ranbaxy; Finnish court reverses earlier verdict on Lipitor
22 February 2006
Merck wins second Vioxx lawsuit
18 February 2006
Ranbaxy raises $400 million from FCCB issue
16 February 2006
Glenmark Pharmaceuticals announces new drug discovery for obesity
13 February 2006
Glenmark Pharmaceuticals Clinical Research unit in India receives ANVISA approval
08 February 2006
Ranbaxy forms South African JV to sell AIDS drug
06 February 2006
Dr Reddy's, Ranbaxy lead race to acquire 3i's stake in Betapharm
03 February 2006
Merck allows Dr Reddy's to sell authorised generics of blockbuster drugs
02 February 2006
Dr Reddy's Laboratories enters into agreement with Merck
01 February 2006
Natco Pharma acquires 75 per cent in US retail store
31 January 2006
Boston Scientific beats J&J to acquire Guidant for $27 billion
25 January 2006
Aurobindo receives UK MHRA approval
20 January 2006
Strides Arcolab signs partnership with The Clinton Foundation for HIV Drugs
13 January 2006
Ranbaxy in co-marketing agreement with Ferring of Switzerland
10 January 2006
Dishman Pharmaceuticals clarifies news item
06 January 2006
Shasun Chemicals signs LoI with to acquire plants, processes, patents of French firm
06 January 2006
JB Chemicals, Taro Pharmaceutical in product development agreement
05 January 2006
Glenmark Pharmaceuticals acquires Bouwer Bartlett, South Africa
26 December 2005
Wockhardt amongst first to receive US FDA approval for Zonisamide Capsules
26 December 2005
Roche grants Tamiflu licence to Hyderabad firm Hetero Drugs
24 December 2005
US FDA grants tentative approval to Aurobindo''s anti-AIDS drug for children
23 December 2005
Merck, ICMR to conduct joint trials on cervical cancer vaccine
22 December 2005
Ranbaxy, Cephalon to settle Provigil patent litigation
22 December 2005
JB Chemicals to set-up wholly owned subsidiary in Russia
21 December 2005
Dishman Pharmaceuticals acquires IO3S, Switzerland
20 December 2005
Natco Pharma finalises terms for supply of two onco formulations
20 December 2005
US FDA approves Lupin's cefprozil suspension, Orchid's tablets
20 December 2005
Ranbaxy to appeal US District Court decision upholding Pfizer Atorvastatin Patents
19 December 2005
TCS to provide end-to-end clinical trial data management solution for Novo Nordisk
19 December 2005
Zydus Cadila to set up JV with Bharat Serum; files second IND
16 December 2005
Glenmark Pharmaceuticals, InvaGen Pharmaceuticals in marketing tie-up
15 December 2005
Aurobindo Pharma selected for IDMA''s patents appreciation award.
15 December 2005
Final US FDA approval for Aurobindo''s Mirtazapine oral disintegrating tablets
14 December 2005
Aurobindo Pharma''s anti-AIDS drug selected by WHO
12 December 2005
Natco Pharma receives Patent Appreciation Award
12 December 2005
Transgene Biotek develops oral vaccines for diabetes and Hepatitis B
07 December 2005
Ranbaxy offers to help U S combat avian flu
02 December 2005
Orchid Chemicals hosts presidential visit at its formulations complex
02 December 2005
New Indo-UK JV company to recruit patients for drug trials
01 December 2005
Lupin receives US FDA approval for Cephalexin capsules
01 December 2005
Tentative US FDA approval for Zydus Cadila's gatifloxacin tablets
29 November 2005
Government to set up separate pricing models for different drug categories
28 November 2005
Ranbaxy honours scientists for outstanding research
28 November 2005
Lupin receives IND approval from DCGI for Desoris LLL-3348
28 November 2005
Nicholas Piramal India Limited signs 10-year manufacturing and supply agreement
24 November 2005
US Court of Appeals upholds preliminary injunction against Ranbaxy
23 November 2005
AstraZeneca sues Ranbaxy on Nexium patent
22 November 2005
Zydus Cadila receives approval for Sertraline from AFSSAPS, France
22 November 2005
Ranbaxy scores over Pfizer in Norwegian court over cholesterol drug
10 November 2005
Orchid Chemicals' fire victims were insured: K Raghavendra Rao
08 November 2005
Dr Reddy''s to acquire Roche business in Mexico
08 November 2005
Venkat Pharma secures $400,000-US order for dietary supplements
02 November 2005
AstraZeneca and Nicholas Piramal sign ''development and know-how'' agreement
27 October 2005
Nicholas Piramal acquires UK''s Avecia for £9.5 million
27 October 2005
CRISIL reaffirms Ranbaxy''s outstanding ratings despite court ruling
15 October 2005
Glenmark Pharmaceuticals targets GPs
10 October 2005
Orchid, AstraZenwca, receive Frost and Sullivan pharma awards
03 October 2005
Zydus Cadila receives tentative US FDA approval for Ribavirin tablets
03 October 2005
Aurobindo receives approval for sertraline hydrochloride tablets
27 September 2005
Unichem Laboratories to step up R&D from Bangalore
23 September 2005
Matrix acquires 43 per cent stake in Swiss firm Explora Labs
21 September 2005
Pharma sector to top Rs.60,000 crore by ''08
21 September 2005
NPPA revises 16 bulk drug prices
20 September 2005
Government evaluating ''data exclusivity'' demand of pharma companies
17 September 2005
Eisai becomes first Japanese pharma firm to enter India
17 September 2005
Ranbaxy obtains US FDA approval for high BP drug
14 September 2005
Shanta Biotechnics launches 4-in-1 combination vaccine
20 August 2005
Eli Lilly launches anti-diabetes drug variant
11 August 2005
Sun Pharma to buy manufacturing site in Hungary
11 August 2005
Wockhardt becomes only pharmaceutical Superbrand in India
20 July 2005
Wockhardt joins $billion league
20 July 2005
Aurobindo Pharma plans to raise funds from global markets
06 July 2005
Ranbaxy, JB Chem to market Doktor Mom brand in Romania
06 July 2005
Maharashtra FDA questions claims of nutraceuticals
28 June 2005
Matrix Labs acquires Belgian drug firm Docpharma for $263 m
20 June 2005
German Remedies launches anti Leukaemia drug
09 June 2005
Nectar Lifesciences to come out with Rs100cr IPO
07 June 2005
Kopran to shift focus to global markets
06 June 2005
Zydus Cadila commences phase I clinical trials on ZYH1
03 June 2005
USFDA gives tentative nod for Ranbaxy drug
01 June 2005
Zydus in JV with Australia's Mayne to manufacture oncology products in India
19 May 2005
Diovan receives EU approval for the treatment of heart attack survivors
10 May 2005
HCL Tech and IIT Delhi to work on new drugs
04 May 2005
Shantha Biotech introduces "JENCEVAC" vaccine to combat fatal brain fever
18 April 2005
Quintiles expands India operations with new clinical data management services
12 April 2005
Johnson & Johnson launches the stent war
29 March 2005
Glenmark acquires another brand in Brazil
18 March 2005
Patent Bill to be introduced next week
17 March 2005
Orchid in deal with Stada for generic drug products
17 March 2005
Mexican mission woos Indian drug majors
16 March 2005
GSK India announces buyback
15 March 2005
On the clinical trial trail
11 March 2005
Zydus ties up Mallinckrodt to market generics in USA
10 March 2005
GlaxoSmithKline to locate first Indian vaccine plant at Nashik
23 February 2005
Global pharmaceutical firms plan investments in India
19 February 2005
Nicholas Piramal signs seven alliances
19 February 2005
GlaxoSmithKline Q4-05 up at 61.4%
17 February 2005
Wockhardt launches India''s first automatic insulin delivery device and recombinant insulin cartridge
17 February 2005
The rest didn''t do badly, either
16 February 2005
Dr Reddy''s cardio drug candidate undergoing clinical trials
09 February 2005
Zydus Cadila files its first IND application for new molecule
09 February 2005
InnoCentive signs MoU with IICT, Hyderabad
04 February 2005
Pharma, IT to benefit from patents: Evalueserve
04 February 2005
Zydus Cadila receives US FDA approvals for Clindamycin
01 February 2005
Ranbaxy makes three fresh ARV filings to WHO
25 January 2005
Shantha Bio launches DNA Erythropoietin
24 January 2005
Ranbaxy Top brass reshuffled
22 January 2005
Dr Mahendra Patel joins Zydus Pharmaceuticals
20 January 2005
Ranbaxy Q4 results disappoints
19 January 2005
Zydus Cadila to host second international symposium on genomics and proteomics
14 January 2005
Shantha Biotech Introduces Shanvac-B in BD UnijectT
10 January 2005
New Year rings in new patents regime for pharma cos
01 January 2005
Nicholas Piramal to take over UK''s Rhodia
18 December 2004
Zydus and Mayne (Australia) sign MoU for JV in India
13 December 2004
Bonanza ahead for generic drug majors
09 December 2004
Sun Pharma to issue $75 million FCCB
06 December 2004
Pankaj Patel declared 'best pharma man of the year' by FIIE
01 December 2004
Sun Pharma launches $225 million FCCB
19 November 2004
Paswan caps drug prices
18 November 2004
Ranbaxy withdraws its antiretroviral''s from WHO list
10 November 2004
Stronger performance from Shasun Chemicals and Drugs Limited
18 October 2004
CII pharma summit for ''India pharma Inc''
13 October 2004
Hanmer & Partners acquires Doc Asia
27 August 2004
Nicholas Piramal finalises product in-licensing agreement with Ethypharm, France
18 August 2004
Fortis to invest over Rs1,100 crore in integrated healthcare delivery system
17 August 2004
Nicholas Piramal in research collaboration with National Institute of Immunology
12 August 2004
Nicholas Piramal seals an in-licensing agreement with Genzyme Corporation for the Indian market
11 August 2004
Dishman Pharma setting up new R&D facility
11 August 2004
Professionals take over
06 August 2004
Sun Pharmaceuticals proposes share swap with Phlox Pharma
03 August 2004
Ranbaxy net down six per cent
02 August 2004
Orchid registers turnover of Rs173.86 crore for Q1 FY 2004-05
31 July 2004
Charak Pharma in joint venture with IL&FS Investmart
23 July 2004
Acer and TVS Electronics enable sales force automation for Dr Reddy's Laboratories
20 July 2004
India emerges as global hub for pharma outsourcing
12 July 2004
Jagsonpal spreads its wings
10 July 2004
Pen G industry demands a strong shot
01 July 2004
Natco Pharma unveils new drug
26 June 2004
Medicine Shoppe to double number of outlets this fiscal
25 June 2004
Biological E to launch hepatitis-B vaccine `Bevac` in three months
16 June 2004
Jagsonpal amongst India's top fifty pharma companies
16 June 2004
Cadila eyes overseas growth opportunities
09 June 2004
FIIs pull out of Dr Reddy''s Laboratories
31 May 2004
Krebs to diversify
31 May 2004
Interview with Sandoz GmbH CEO Christian Seiwald
31 May 2004
Orchid in tie up with Par Pharmaceuticals Inc. to market oral cephalosporin in the US
28 May 2004
Sun Pharma plants get US regulatory clearance
28 May 2004
Two Sun Pharma units gets USFDA approval
27 May 2004
Granules India gets USFDA nod
24 May 2004
Orchid's US discovery JV successful
22 May 2004
Ipca launches India's first novel injectible antibiotic combination
20 May 2004
Orchid files ANDA for Cefazolin finished dosage form
15 May 2004
Templeton Strategic acquires 2.9 per cent stake in Aurobindo Pharma
08 May 2004
Dr Reddy''s acquires US company Trigenesis
07 May 2004
Wockhardt acquires German firm Esparma
07 May 2004
Sanofi India's fortune looking up
05 May 2004

03 May 2004
Jagsonpal Pharma net rises 227 per cent
03 May 2004
Ranbaxy in pact for new drug discovery
30 April 2004
Novartis launches development centre in Mumbai
28 April 2004
Zydus Cadila reports highest ever sales, net profits up 87 per cent
27 April 2004
Global pharma eyes India as BPO hub
26 April 2004
Orchid's net profit rises 59 per cent on Rs 713 crore turnover during '03 -'04
26 April 2004
1:1 bonus from Sun Pharma
24 April 2004
Maxfair Drugs launches ayurvedic formulations in Kerala
24 April 2004
Suven Life Sciences institutes scientific advisory board for CNS research
13 April 2004
Orchid Pharma soon to file ANDA from its new plant
13 April 2004
Orchid Pharma soon to file ANDA from its new plant
02 April 2004
Zydus Cadila gears up for the US market
02 April 2004
Shreya launches new generation ''Viagra'' variant
01 April 2004
Nicholas Piramal, Indian Institute of Science to develop anti-fungal drugs
31 March 2004
Orchid granted Certificate of Suitability for Cefadroxil Monohydrate
30 March 2004
Proalgen Biotech to expand operations
29 March 2004
Dishman IPO price band finalised
25 March 2004
Nicholas Piramal expands its Clinical Research facility
24 March 2004
Orchid to raise USD 75 million through FCCBs
20 March 2004
GlaxoSmithKline, Burroughs Wellcome boards approve merger
18 March 2004
Zydus Cadila launches Nucoxia
17 March 2004
Sun Pharma increases holding in Caraco
16 March 2004
Matrix Labs gets US approval for second unit
13 March 2004
Ranbaxy crosses the billion dollar mark
11 March 2004
Morepen gets USFDA approval for API manufacturing
09 March 2004
US reinsurers wary of Indian pharma firms
09 March 2004
Product patents a major issue at Bio Asia
01 March 2004
Pfizer recalls liquid Gelusil
28 February 2004
One more CoS for Orchid Chemicals
19 February 2004
Pharmexcil to be headquartered in Hyderabad
10 February 2004
Sun Pharma to increase holdings in Caraco to 60 per cent
09 February 2004
Nicholas Piramal merges Canere Actives and Fine Chemicals Pvt. Ltd.
07 February 2004
Nicholas Piramal Q3 growth up 76.1 per cent
07 February 2004
Sun Pharma logs healthy growth
03 February 2004
Ranbaxy enters the field of herbal medicine
22 January 2004
HAL and RCF divestment gains momentum
19 January 2004
Orchid posts good Q3 performance
16 January 2004
USFDA approval for Ranbaxy drug
10 January 2004
Nicholas Piramal, SPPL debt programmes reaffirmed A1+
06 January 2004
Vera Laboratories to come out with a preferential issue
02 January 2004
Orchid Aurangabad facility bags ISO 14001, OHSAS 18001
31 December 2003
Divi''s, Matrix scrip prices cross leading pharma firms'' prices
29 December 2003
Retreat of a titan
29 December 2003
Nicholas Piramal buys partner''s 50% stake in Sarabhai Piramal
26 December 2003
Indian pharmaceutical majors oppose EMR granted to Novartis
23 December 2003
Pfizer India plans to put three manufacturing units on block
22 December 2003
European approval for Orchid Chemical's drug
18 December 2003
Ranbaxy''s first round of talks to acquire RPG Life Sciences over
05 December 2003
USFDA approval for Orchid
05 December 2003
WHO declares pre-qualification of Ranbaxy''s Triviro-LNS tablets
04 December 2003
Bexel to conduct human trials
03 December 2003
Nicholas Piramal enters into alliance with Biogen Idec, USA
02 December 2003
Torrent to increase presence, set up export base in Germany
22 November 2003
Novo Nordisk unveils 2 insulin
10 November 2003
Orchid income at Rs 162 crore
04 November 2003
Bilcare net profit rises 55%
21 October 2003
FIIs hike stake in Lupin, Cadila Healthcare, Aurobindo Pharma
20 October 2003
Zydus Cadila Q2 net rises 30%
20 October 2003
Lupin to restructure board; to licence out new chemical entity
13 October 2003
Hikal gets ICRA''s A1+ rating for short-term debt programme
10 October 2003
Bilcare bags OPPI award for best packaging material in 2003
08 October 2003
Glenmark Pharmaceuticals plans major foray into US markets
08 October 2003
Orchid Pharma's API facilities inspected by EDQM, MHRA UK
06 October 2003
Caraco Pharma gets USFDA nod for tizanidine hydrochloride
03 October 2003
Nicholas Piramal follows MNC pharma companies'' strategy
03 October 2003
Nicholas Piramal rolls out growth plan; Maini, Chaudhuri on board
03 October 2003
Zydus Cadila becomes a partner of choice for Schering AG
03 October 2003
Cadila plans major foray into generics market in US, Europe
30 September 2003
In the giving phase of life
25 September 2003
Kopran may rope in strategic financial partner for recast plan
24 September 2003
Unichem Laboratories to set up formulations facility in Himachal
24 September 2003
Ranbaxy to invest Rs 120 crore for R&D in Andhra Pradesh
22 September 2003
Meet brings to fore opportunities in European pharma industry
22 September 2003
SC order to expedite pending merger of Pharmacia with Pfizer
22 September 2003
Orchid JV manufacturing facility in China commissioned
20 September 2003
Cipla eyes formulations exports to attain Rs 17-billion turnover
15 September 2003
Human touch for humanity
05 September 2003
Jitendra N Doshi to be interim chief of Caraco Pharmaceuticals
30 August 2003
Mumbai to host Global Pharma Business Convention soon
23 August 2003
Hikal''s main focus : Pharma
09 August 2003
Orchid's API and formulation facilities receive TGA approval
01 August 2003
Aurobindo Pharma to invest Rs 50 crore for R&D centre in Mumbai
29 July 2003
Sun Pharma Q1 net, sales rise
28 July 2003
Orchid Chem Q1 profits up
25 July 2003
FIIs, banks up holdings in Ranbaxy, Dr Reddy''s, Nicholas Piramal, Cipla
21 July 2003
In the pink of health
21 July 2003
Double (dis)advantage
16 July 2003
Cadila Healthcare sales up 16.1%
15 July 2003
Hikal declares bonus share of 1 : 2
14 July 2003
Lupin promoter D B Gupta to sell 12.5% stake to Newbridge
10 July 2003
Wockhardt buys CP Pharma
10 July 2003
Ind-Swift Labs net up 25% in FY 2002-03, 50% in last quarter
01 July 2003
Orchid's US drug discovery JV progresses well on BLX 1002
01 July 2003
Bombay HC okays merger of German Remedies with Cadila
28 June 2003
There is no plan to sell Vitamin B12 business, says Wockhardt
24 June 2003
Orchid, Apotex in exclusive pact to sell injectable antibiotics in US
03 June 2003
Suven Pharma acquires assets of NJ-based Synthon Chiragenics
20 May 2003
Citigroup to finalise Rs 300-cr equity investment deal in Lupin
09 May 2003
Pharma MNCs to tap Indian market post-patent regime
09 May 2003
Sun Pharma to invest Rs 25 cr in Jammu; posts good results
05 May 2003
Zydus Cadila's net profit zooms by 27%
03 May 2003
Orchid registers Rs 541-crore turnover; posts 27% growth
02 May 2003
MNC and Indian companies in race to acquire Paras Pharma
29 April 2003
Kee Pharma offers Melagenina Plus for vitiligo patients
24 April 2003
BIFR issues show-cause notice to wind up Sol Pharmaceuticals
19 April 2003
Access to medicines
17 April 2003
Morepen defaults on FDs; hit by slump in Loratadine prices
17 April 2003
Elder, Ajanta, Glenmark may buy known therapeutic brands
11 April 2003
Indian pharma sector on path to prepare for global collaboration
24 March 2003
VAT may push prices of drugs, manufacturing goods by 5%
17 March 2003
Domestic Viagra market to sizzle as Kopran cuts price of Nyte
17 March 2003
Zydus Cadila to launch new line of treatment for kala azar
15 March 2003
GlaxoSmithKline announces a dividend of Rs 7 per equity share
13 March 2003
Shasun launches Shacryl-30 D; gets US company’s licence
03 March 2003
India asked to lead battle against developed world on patent issue
26 February 2003
Major pharma companies in race for acquiring RPG Life Sciences
26 February 2003
Orchid Pharma's Cephalexin approved by USFDA, EDQM
24 February 2003
Medicine Shoppe, Bajaj Allianz to offer free insurance cover
24 February 2003
Argonne National Lab joins Joint Indo-American Bioinformatics
12 February 2003
Glenmark Pharmaceuticals to divest subsidiary for Rs 35 crore
10 February 2003
Share swap ratio of merger of Cadila, German Remedies at 7:4
05 February 2003
Orchid Chemicals net down to Rs 9.51 cr; turnover at 346.45 cr
28 January 2003
Novartis discontinues development of Dr Reddy’s compound
24 January 2003
Chemtech + Pharma World Expo to start in Mumbai on 22 Jan
18 January 2003
EMD Pharma awards Aker Kvaerner cell culture project
16 January 2003
DCGI asks ICMR to chart guidelines for stem-cell research
13 January 2003
Zydus Cadila, Berna Biotech tie up to develop cancer vaccines
13 January 2003
IDBI may bid again for strategic sell-off of Hind Antibiotics
11 January 2003
GlaxoSmithKline declares second interim dividend of 37%
21 December 2002
Sun Pharmaceuticals approves resolutions for split, buyback
21 December 2002
Orchid Chemicals acquires Mano Pharma, Sali Healthcare
17 December 2002
Novo Nordisk ignores IPR, to launch new products in India
13 December 2002
Multinational, domestic pharma firms lock horns over R&D data
09 December 2002
Caraco, Sun Pharma sign R&D pact for 25 new generic drugs
09 December 2002
Glaxo SmithKline defers merger with Burroughs Wellcome
09 December 2002
Ranbaxy to provide AIDS drugs to 10 lakh patients
29 November 2002
Gland Pharma sets up R&D centre near Hyderabad
28 November 2002
Alembic gets nod to market third-generation cephalosporin drug
27 November 2002
Morepen to reposition Dab range, add more flavour to C-Sip
19 November 2002
Alembic to diversify into speicalty chemicals, biotechnology
18 November 2002
BIFR, lenders reject IDBI bid to sell Hindustan Antibiotics
13 November 2002
Orchid Chemicals procures USFDA approval for Cephalexin
11 November 2002
Kopran promoters, FIs, banks offload 18% stake in company
08 November 2002
Novartis acquires global rights for Torrent’s AGE compound
07 November 2002
Hikal clocks 28% sales growth at Rs 32 crore in second quarter
31 October 2002
Cheryl’s Cosmetics to expand operations, to train professionals
29 October 2002
Sun Pharma clocks 12% turnover, 14% PAT increase in Q2
29 October 2002
Ranbaxy Laboratories clocks Rs 1,594-million Q2 net profit
18 October 2002
Morepen Laboratories net profit up to Rs 168 million in Q2
14 October 2002
Dr Reddy’s Labs to appeal US court ruling on infringement
14 October 2002
Boots Piramal to enter vitamins, minerals, food supplements
10 October 2002
India emerges hot market for human drug development testing
08 October 2002
Reliance Life Sciences develops stem cells to treat heart diseases
07 October 2002
Government likely to amend D&C Act to curb illicit drug trade
07 October 2002
SSI plans to launch BCG, rabies vaccines soon
04 October 2002
Ranbaxy secures 10% stake in Nihon Pharma
26 September 2002
Ranbaxy gets USFDA approval for Terazosin
26 September 2002
RPG Life unveils nephrocare pharma division
24 September 2002
Bayer recasts activities, gets into OTC sector
20 September 2002
DCI team clears Sun Pharma research facility
18 September 2002
Matrix to merge Vorin, Medicorp with itself
16 September 2002
Nicholas Piramal hikes its stake in JV by 9%
09 September 2002
Novartis sale of property to Kingston through
09 September 2002
Max India to exit pharmaceutical business
05 September 2002
Hikal, Rockwell in enterprise integration JV
02 September 2002
Dr Reddy’s grants employee stock options
27 August 2002
Ranbaxy refutes Glaxo’s charge of stealing
24 August 2002
Glaxo SmithKline to sue Novartis, Ranbaxy
23 August 2002
Himalaya unveils women’s healthcare drugs
23 August 2002
Alembic to launch new drug delivery system
05 August 2002
Ajanta net up 278%, exports zoom 358%
29 July 2002
Hikal net rises by 16%, thrust on pharma
24 July 2002
Ranbaxy acquires Signature Pharma facility
23 July 2002
Orchid Chemicals in equal JV with NCPC
20 July 2002
Magan Industries forays into biotech, pharma
17 July 2002
Orchid Chemicals to go slow on nutraceuticals
31 May 2002
Maharashtra FDA plans to apply GMP rules
22 May 2002
IAVI to begin human trials on HIV vaccine
22 May 2002
Unichem gets MCA nod for HP plant
18 March 2002
Astra open offer for Indian subsidiary
09 March 2002
In placebo limbo?
08 February 2002
Maharashtra hikes drug license fee
08 February 2002
Pharma sector fared well in 2001
28 December 2001
Kerala to preserve, promote ayurveda
24 December 2001
Zydus website on healthy lifestyle
15 December 2001
Sildenafil citrate drug sales surge
05 December 2001
in China
28 November 2001
Dr Reddys to challenge patents on drugs
26 November 2001
Iodex goes to SmithKline Healthcare
26 November 2001
Andhra Pradesh to set up Pharma City
23 November 2001
Alembic to rejig business operations
15 November 2001
Wockhardt files investigational application
15 November 2001
Rediscovering Indian pharma market
10 November 2001
Morepan to file nine drug applications
07 November 2001
Advanced anthrax vaccine developed
06 November 2001
Cadila Pharma gets US, UK patents
06 November 2001
Dr Reddys Labs launches Hyalosyn
06 November 2001
Sun Pharma to bifurcate subsidiary
03 November 2001
Zydus Alidac launches Bonmax
03 November 2001
Cipla comes under Sebi investigation
25 October 2001
Imunus launches 2 new Aids molecules
24 October 2001
Lupin to make HIV cocktail drugs
24 October 2001
Ranbaxy gets nod for Lisinopril
24 October 2001
Unichem in pact with IIS
24 October 2001
Pharma firms set to fight anthrax
16 October 2001
Aventis expects Arava to do well
12 October 2001
Caraco makes, markets two drugs in US
04 October 2001
Ajanta to offload stake in Kazakh firm
26 September 2001
Ajanta, Kopran drop plan to buy brands
20 September 2001
Zydus Cadila, Kopran join hands
18 September 2001
Chinese pharma units to face anti-dumping duty
17 September 2001
Oushadi to make veterinary medicines
14 September 2001
Dr Anji Reddy felicitated by IPA
28 June 2001
Pfizer joins hand with Microsoft and IBM for healthcare venture
05 April 2001
Drug major changes policy for AIDS drug
16 March 2001
Chemists prepare for face-off with manufacturers
16 March 2001
Abbott revives growth prospects with BASF acquisition
18 December 2000
Glaxo SmithKline reaches agreement with US FTC
18 December 2000
Eli Lilly arthritis drug deal a forerunner for acquisition ?
17 November 2000
Nycomed-Amersham to move research to China
14 November 2000
Popular medicines pulled out of shelves by regulators
14 November 2000
Pharma companies combine forces to battle spurious drugs
30 October 2000
List of bulk drugs under Drug Price Control Order
08 March 2000
NPPA slashes prices of two bulk drugs
08 March 2000
Zandu, CMI to jointly develop drug for Parkinson's disease
11 February 2000
US FDA to formulate new guidelines for botanicals
11 February 2000
Zandu has six more products in pipeline
11 February 2000
Pfizer acquires Warner Lambert
07 February 2000
Merger impact in India
07 February 2000
Global sales up nine per cent
19 January 2000
Glaxo Wellcome, SmithKline Beecham agree to merge
17 January 2000
Large market share
17 January 2000
Why the merger worked this time
17 January 2000
About Novopharm
13 January 2000
Ranbaxy to sell ranitidine 75mg tablets in the US
13 January 2000
The Medicine Shoppe
07 January 2000
Rationalising drug distribution in India
07 January 2000
Foreign investment limit raised to 74%
06 January 2000
Age-related macular degeneration
03 January 2000
Ajanta Pharma's drug for macular degeneration
03 January 2000
Abbreviated New Drug Application (ANDA)
01 January 2000
Distribution margins in India
01 January 2000
RDCA to form retail co-operative society in Mumbai
01 January 2000
Drug distribution channels
01 January 2000
Subiksha
01 January 2000
NPPA revises prices of 26 formulations
28 December 1999
Table of revised/fixed prices
28 December 1999
Marketing alliances can hurt
25 November 1999
Pharmaceutical exports up 3 per cent
16 November 1999
Ban on vitamins only on high-dose formulations
16 November 1999
Nicholas Piramal will gain from vitamin A price hike
10 November 1999
Vitamin A manufacturing process
10 November 1999
If Wyeth takes Parke Davis ... if Pfizer does?
06 November 1999
Vitamin A - unattractive business?
06 November 1999
Novartis, Nicholas to buy Hoechst units
16 October 1999
Hoechst keen on analgin exports
07 October 1999
Unichem eyeing analgesic brands
22 September 1999
Unichem financial highlights: 1998-99
22 September 1999
Unichem launches women's healthcare division
22 September 1999
Alpha drugs referred to BIFR
14 September 1999
Alpha drugs referred to BIFR
10 September 1999
Two views on controls
10 September 1999
Ranbaxy closes $65 million Bayer deal
09 September 1999
Ranbaxy to raise research spending to 6 per cent of sales by 2002
09 September 1999
Drug prices revised, Wockhardt to gain
13 August 1999
J&J hives off adhesives unit to Premchand group
12 August 1999
Norton Healthcare ties up with Nicholas Piramal, RPG Life Sciences
06 August 1999
India likely to attract clinical trials projects for new drugs
04 August 1999
Nicholas Piramal buys four Eli Lilly brands
22 July 1999
Ode to a visionary
04 July 1999
Hoechst, Nicholas Piramal to co-market two products
01 July 1999
Ranbaxy in talks with Bayer for licensing ciprofloxacin delivery system
25 June 1999
Dabur launches anti-hepatitis product
23 June 1999
Formulations grew 14% in 1998: IMS
21 June 1999
Glaxo, Ranbaxy, Cipla top rankings in 1998: IMS
21 June 1999
Glaxo, Ranbaxy, Cipla top rankings in 1998: IMS
21 June 1999
Contract manufacturing: new vistas for Indian pharma companies
14 June 1999
BIFR declares Paam Pharma sick
31 May 1999
Zandu's US trials for anti-Parkinson drug
31 May 1999
Ranbaxy pushes Pravosin to phase-1 trials
30 May 1999
Hoechst puts four brands on the block
29 May 1999
Bayer, Zydus end joint venture
21 May 1999
Glaxo acquires five veterinary brands from ICI
20 May 1999
Cheminor unfazed by AstraZeneca patent infringement suit
13 May 1999
Boots to sell Piramal ayurvedic products in Europe
12 May 1999
Ajanta, Ranbaxy plan co-marketing
27 April 1999
Wockhardt preparing for competition
27 April 1999
Aurobindo turns cold on Dee Pharma unit
24 April 1999
NPPA losses charm as govt clips price fixing powers
24 April 1999
Cipla eyes US generics market, in talks for alliance
22 April 1999
Parke-Davis to extend Benadryl brand name
22 April 1999
Zidovudine will boost Glaxo
22 April 1999
Abbott Labs diversifying
01 September 1998
Abbott's new businesses, low-cost oppurtunism
01 September 1998
 search domain-b
  go